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ABSTRACT 
 
MICROBIOTA ACTIVATED CD103
+
 DCS STEMMING FROM ORAL 
MICROBIOTA ADAPTATION SPECIFICALLY DRIVE γδT17 PROLIFERATION 
AND ACTIVATION 
 
Christopher Jay Fleming 
April 13
th
 2016 
 
IL-17 producing γδ T cells (γδT17) promote numerous autoimmune diseases such as 
psoriasis and arthritis, as well as, cancers of the colon, lung and breasts.  Yet γδT17 
peripheral regulation has yet to be thoroughly explored.  In mice deficient in IL-17 
signaling, we observed expansion of γδT17 in all major tissues.  However, γδT17 
expansion was not uniformly distributed systemically and was most prominent in oral 
draining cervical lymph nodes (LNs) with monoclonal expansion of Vγ6 γδT17.  In 
vitro proliferation assays of these cervical LNs showed endogenous proliferation by 
γδT17 dependent on cell-to-cell contact with CD103
+
 DCs.  CD86
+
 and CD80
+
 
activated CD103
+
 DCs are increased in the oral draining LNs suggesting that perhaps 
microbiota-activated CD103
+
 DC expand γδT17.  16s rRNA FISH hybridization 
v 
 
shows increase in 16s rRNA in oral draining LNs.  Treatment of mice deficient in IL-
17 signaling with α-LTBR-Ig (to remove LNs) or oral broad-spectrum antibiotics 
abrogates γδT17 expansion.  Cohousing IL-17r
-/- 
mice with wild type mice induces 
γδT17 expansion in the wild type mice also showing increase numbers of activated 
CD80
+
 and CD86
+
 CD103
+
 DCs in the oral draining LNs.  In germ-free mice which 
lack microbiota, γδT17 expansion is significantly inhibited while γδT17 cells are 
expanded in a Porphyromonas gingivalis oral infection model.  γδT17 are promoters 
of different devastating diseases and this study provides new evidence showing they 
can be regulated by CD103
+
 DCs providing a new and specific cell-to-cell interaction 
that could be targeted by future therapeutics. 
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 1 
INTRODUCTION 
“If two people stare at each other for more 
than a few seconds, it means they are about 
to either make love or fight. Something 
similar might be said about human societies. 
If two nearby societies are in contact for any 
length of time, they will either trade or fight. 
The first is non-zero-sum social integration, 
and the second ultimately brings it.”  
― Robert Wright 
  
General Introduction 
The world we live in consist of interactions between groups that are either 
advantageous at the beginning or is in the process of becoming advantageous.  The same 
can be said on the microscopic level as groups of cells and microorganisms interact and 
seek benefits to bring about survival short-term and prosperity long-term.  To an outsider 
this complex array of interactions might initially seem chaotic and random; however as 
knowledge builds about each individual 
interaction more can be said about the 
array of interactions on a whole like 
learning the steps of a beautiful dance.  At 
the host-environment interface, the 
immune system is one community and the 
Figure 1 A Microbiota Dance Party 
(Scott Charles Anderson ©2014) 
d 
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microbiota is another.  They learn from their interactions in order to bring about better 
and more efficient responses like two dance partners learning how the other moves and 
responds which is beneficial to the partnership and to the individual. 
The immune system does not learn and dance for the sake of it but instead to 
bring about resilience and security to the host.  The network of immune cells and the 
interactions within is immense and incredible but even within such beauty lays incredible 
control and order.  Every cell is created for a specific process that has been selected due 
to millions of years of environmental pressures and cues.  If a cell does not help in 
bringing forth prosperity to the host then it is removed.  Cells of the healthy and thriving 
immune system do not exist due to mistake or accident.  Each cell has a specific purpose 
and even if redundancies in the system exist there must be a specific niche or unique 
purpose for each 
cell otherwise 
that cell would 
no longer 
subsist. 
Rare 
cells of the 
immune system 
are of particular 
interest especially 
when you see them conserved throughout millions of years of evolution.  T cells 
expressing the gamma and delta chain of their T cell receptor (γδT) evolved hundreds of 
Figure 2.  Conservation of ancient immune functions during the evolution of 
complex life forms. (Hofmann et al., 2010) 
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millions of years ago back to the origin of cartilaginous fish and have persevered 
throughout the evolution of man (Figure 2).  They exist because they are important in 
some process(s) yet they remain rare and obscure.  To be rare and obscure requires 
tremendous control thus energy.  The host’s need to use up energy to control such an 
obscure population is intriguing to say the least.  Balance is a critical aspect of life and 
there are many examples of how when cells of few become cells of many suffering and 
tragedy shortly follows.  Therefore the rare cells must be tightly controlled and regulated 
so the host continues to thrive. 
Interestingly some of the most rare and least known cells of the immune system 
exist at the host-environment interface where it would seem the least amount of control 
could be achieved.  The most distal areas of the body, away from the developmental 
organs of the immune system which includes the thymus, liver, spleen and bone marrow, 
are the epithelial surfaces such as the skin, respiratory and GI tracts.  These are the 
surfaces containing the highest numbers of microbiota.  This is where self meets and 
interacts with non-self constantly.  This is where the dance is most active and the most is 
being learned.  This host-environment interface is the educational center of the innate 
immune system similar to the thymus for the adaptive side.  This is where our immune 
system interacts and processes a mindboggling amount of data in order to determine what 
actions are needed in order to bring survival and prosperity to the host. 
Interactions between two of the least frequent yet most potent populations of the 
immune system and their response to a changing microbiota is the subject of this 
dissertation.  They are γδ T cells and CD103
+ 
dendritic cells (DC) which often only make 
up approximately 0.3-4% of the total hematopoietic cells present in the tissues discussed.  
 
 4 
If the immune system is compared to a spear touching its sharp tip against the microbiota 
world to determine if its safe or dangerous, the γδT and CD103
+
 DCs would be that tip 
(Figure 3).   Even a rare 
and obscure population 
of cells can have a 
tremendous impact on 
the health and 
prosperity of the host.  
γδ T cells  
 γδ T cells are named for their variable Vgamma (γ) and Vdelta (δ) TCR chain 
usage, which is different than the alpha beta (αβ) chains of the more conventional CD4
+
 
and CD8
+
 T cells.  This alternative TCR expressing T cell was discovered in 1986 by 
three separate labs leading to three consecutive Nature publications in 1986 and 1987 
(Bank I, 1986; Brenner M.B., 1986; Pardoll DM, 1987).  The lymphocyte section of the 
immune system was thus divided into a tripartite system of αβ T cells, B cells and γδ T 
cells.  A tripartite lymphocyte system has been observed and traced back to the most 
ancient of species some 450 million years ago (Hayday, 2000).  With γδ T cells being 
such a rare population immunologist were instantly intrigued by their conservation for 
hundreds of millions of years.  Obviously, an unknown importance was involved and has 
been a topic of investigation for the last thirty years. 
By now, substantial progress in determining the functional roles and underpinning 
mechanisms of αβ T cells and B cells has been achieved.  However, γδ T cells were more 
of less cast aside due to their small numbers and their TCR variable chains appeared for 
Figure 3. γδT and CD103 DCs are protectors of epithelial integrity 
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the most part invariable compared to the mindboggling variability of the αβ TCR and B 
cell BCR (Li et al., 1998).  Lack of MHC Class I or II restriction and the ability to 
recognize different antigens of biochemical makeup and size made γδ T cells appear as 
innate immune cells rather than cells of adaptive immunity (Asarnow DM, 1988).  
Nevertheless, some immunologists were intrigued and began investigating the 
development, trafficking and effector function of γδ T cells in various mouse models 
even though it was not till later physicians became aware of the presence of γδ T cells in 
many human diseases in the clinic.  Development has been one of the major areas of γδ T 
cell investigation because this particular subset has a very spatially and temporally 
defined maturation process.  γδ T cell progenitor cells are formed in either the fetal liver 
or bone marrow during early embryogenesis and the vast majority are matured in the 
thymus in the last week of embryogenesis.  There are also γδT cells which develop 
extrathymically that have been observed in athymic mice (Preffer FI, 1989).  γδT cells 
are divided into two separate populations based on their effector cytokine production 
which is selected for intrathymically during this last week of development based on 
antigen exposure (Ribot et al., 2009).  They are separated into IFN-γ producing and IL-17 
producing γδ T cells. IFN-γ producing γδT cells are known to directly engage and kill 
virus infected or cancerous cells analogous to CD8
+
 T cell responses except much 
quicker and less specific.  γδT17 cells during health provide assistance to other cell types 
similar to that of T helper cells.  As Vantourout and Hayday mentioned in their Nature 
Immunology Review of γδ functions that γδ T cells do not possess a unique function but 
as a heterogenous group with many different functions are unique in their ability to evoke 
these functions all in the same tissue (Figure 4)(2013).  Due to this fact, use of δTCR
-/-
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mice that are deficient in γδT cells must be used very carefully in order to determine 
specific roles of γδT cells. 
  IFN-γ producing γδ T cells are 
positively selected for through strong 
ligand interaction with molecules such as 
SKINT-1 and IL-17 producing cells are 
negatively selected for through weak 
ligand interaction (Barbee et al., 2011; 
Jensen et al., 2008; Ribot et al., 2009; 
Turchinovich and Hayday, 2011).  IFN-γ 
producing γδ T cells reside primarily in the 
blood and lymphatic system including the 
spleen while IL-17 producing cells are primarily found at epithelial surfaces such as the 
skin, lungs, G.I. tract and vagina.  γδ T cells develop earlier than αβ T cells and their 
program of development is synchronously connected to the development of other tissues 
(Carding and Egan, 2002; Shibata, 2012).  Vγ usage is tied to functionality and plasticity 
with some subsets such as Vγ1 and Vγ4 being more plastic with a variety of inducible, 
adaptive-like effector functions while Vγ6 γδ T cells are more programmed, terminally 
differentiated innate-like effector cells (Bonneville et al., 2010). 
γδT17 cells  
γδT17 cells are major producers of IL-17 and are an important source of this 
cytokine at mucosal and epithelial barriers where IL-17 plays a critical role in 
maintaining epithelial integrity.  They can be found in the skin, tongue, lungs, colon, 
Figure 4. Vastly different Functions of γδT cells 
(Vantourout and Hayday, 2013) 
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vagina and upper respiratory tract.  Much investigation has been used in order to 
elucidate the signaling requirements needed for the differentiation of γδT17 cells in the 
thymus.  Hayes and Laird described these  
events in a 2012 review showing at different 
stages throughout the thymus the events 
required for mature effector γδT17 cells to 
develop (Hayes and Laird, 2012) .  It has also 
been reported that Sox4 and Sox13 are 
important transcription factors in the early 
development of Vγ4 γδT17 cells but not Vγ6 
(Malhotra et al., 2013).  A transcription factor 
specific for Vγ6 γδT17 development is still 
unknown.  Evidence suggests that antigen 
exposure in the thymus is important for 
development of IFN-γ γδT cells but not γδT17 cells which show little antigen exposure 
(Jensen et al., 2008).  γδ T cells in humans however show a greater level of plasticity 
with in vitro treatment of Vγ9Vδ2, which makes up approximately 70% of all human γδ 
T cells, with various cytokine cocktails leading to differentiation into different effector 
subsets including IL-17 and IFN-γ producing γδT cells (Caccamo et al., 2013; Moens et 
al., 2011).  Ex vivo staining of human samples however has shown that the majority of 
γδT17 producers in humans express the TCR Vδ1 chain (Wu et al., 2014).  However in 
mice the predominant  γδT17 cells consist of Vγ6
+
 and Vγ4
+
 γδT cells with the majority 
being committed during embryonic development in the thymus.These two different 
Figure 5. γδT17 Develop ment in Thymus 
and Peripheral Regulation 
(Hayes and Laird, 2012) 
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γδT17 subsets in mice appear to develop differently and leave the thymus at different 
times in what has been called “Functional embryonic waves” (Figure 5) (Cai et al., 2014; 
Haas et al., 2012).  As shown in Haas et al.’s diagram, Vγ6 γδT17 cells are developed in 
the thymus before birth meaning that they must undergo self-renewal for long-time 
persistence throughout a host’s life.  
Vγ4 and Vγ1 continue to be 
developed in the thymus and these 
have the added advantage of being 
inducible γδT17 cells (Chien et al., 
2013).  
Disproportionally located in the 
mucosal linings of different organs in 
mice and humans, γδT17 cells are able 
to quickly respond to inflammatory 
events and foreign pathogen insults.  Most studies have shown that γδT17 get activated 
through archaic signals of injury and infection such as inflammatory cytokines, pathogen 
pattern recognition receptors (PPARs) and complement receptors (Martin et al., 2009; 
Sutton et al., 2009; Xu et al., 2010). Vγ1 and Vγ4 γδT17 cells can also be induced to 
produce IL-17 with minimal clonal expansion through TCR-dependent antigen induction 
with phycoeurythrin (PE) (Zeng et al., 2012).  Chien et al.’s study provided a paradigm 
shift in γδT17 biology since we now have two different pathways of γδT17 responses 
much like regulatory Tregs with natural and inducible Tregs.  γδT17 have since been 
looked at as natural and inducible or programmed and programmable.  
Figure 6.  Functional Embryonic Waves of γδT17 cell 
egress from the thymus. 
 (Haas et al., 2012) 
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γδT17 in Health 
IL-17 plays a major role at epithelial barriers as it induces epithelial cells to secrete anti-
microbial products such as defensins in order to maintain microbiota populations (Pappu 
et al., 2012).  γδT17 cells are one of the major contributors of IL-17 and due to their 
innate abilities are the predominant earlier responders to epithelial insults.  This IL-17 
response is important in the release and maturation of neutrophils from the bone marrow 
as well as trafficking of neutrophils into the site of inflammation.  Neutrophils then play a 
role in decreasing the pathogen load and helping to restore the tissue to health (Chien et 
al., 2013).   
γδT17 cells play a critical role in restoring tissue to homeostasis after injury or disease.  
Li et al. found that γδT17 cell are important in corneal nerve regeneration due to the 
downstream effects of IL-17 and VEGF necessary for neutrophil involvement (2011b).  
This is only one of a few reports citing the importance of γδT17 in neuropathology 
however this field is growing tremendously.  Braun et al. using models of lung 
inflammation including bleomycin inhalation was able to show that γδT17 are important 
in controlling the inflammation necessary to restore the lungs to health and prevent 
fibrosis development (2008).   
γδT17 in Disease 
γδT17 cytokine effector function is the primary means in which they have been studied in 
the context of disease. Due to their ability to induce a powerful immune response under 
the necessary circumstances, if they become deregulated it will lead to the initiation and 
progression of various inflammation driven diseases.  Inflammation is a tightly regulated 
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process directing the immune response to initiate and follow through with injury or 
infection resolution.  Their role therefore in the pathophysiology of autoimmune diseases 
and cancer reflects their ability to be potent IL-17 producers thus acting as attractors of 
other immune cells such as MDSCs, macrophages and neutrophils (Rei et al., 2014; 
Shibata, 2012; Wu et al., 2014).   
The role of γδT17 in human colon cancer shows that a vicious γδT17 cycle could play a 
major role in the theory of cancer as a “never healing wound” (Wu et al., 2014).  The 
cycle begins with the initial inflammatory events that activate γδT17 cells either directly 
from injured epithelial cells, local antigen presenting cells such as DCs and/or γδT17 
recognition of foreign material using their own 
PAMP or DAMP receptors.  γδT17 cells then 
attract myeloid-derived suppressor cells 
(MDSCs) or neutrophils to the sight of 
inflammation.  MDSCs are well known for 
their ability to regulate inflammation so that a 
wound or injury can be resolved; however, 
they also produce IL-1β and IL-23 inducing 
proliferation of γδT17 cell.  The increased IL-
17 production will lead to more MDSC 
attraction and accumulation thus propelling 
the cycle (Figure 6) (Wu et al., 2014; Yan and 
Huang, 2014). 
Figure 7. γδT17-MDSC Inflammation Cycle. 
 (Yan and Huang, 2014) 
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IL-17 production not only leads to the accumulation of inflammatory cells known 
to promote various diseases but it is also an upstream signaling pathway for markers 
known to be important in cancer metastasis. IL-17 is a direct upstream and potent inducer 
of VEGF leading to angiogenesis, a hallmark of cancer progression and metastasis.  In 
fact, VEGF blockade led to increase levels of IL-17 which induced additional 
angiogenesis factors leading to cancer progression (Chung et al., 2013).  IL-17 also 
induces the production of metalloproteinases such as MMP-1, 2, 9 and 13 (Feng et al., 
2014; Li et al., 2011a).  These proteins are essential for cell migration through tissue and 
barriers resulting in lymph node involvement and metastasis to other organs.   
γδT17 in Cancer 
γδT17 cells have been shown in five top-
tier journal reports to play an important 
role in the progression of various cancers 
including colon, lung, breast, liver, and 
ovarian.  In colon cancer, γδT17 cells are 
stimulated by microbiota activated 
inflammatory DCs causing them to 
produce vast amounts of IL-17 which 
attracts immune suppressive MDSCs into 
the tumor microenvironment (Wu et al., 
2014).  In a similar mechanism in breast cancer, γδT17 cells attracted neutrophils into the 
breast cancer microenvironment causing them to become suppressive and play a role in 
the metastasis of the disease (Coffelt et al., 2015).  Ma et al. found using a hepatocellular 
Figure 8. γδT17 IL-17 Effector Function in 
Cancer. 
 (Lo Presti et al., 2014) 
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cancer model that γδT17, mainly Vγ4, recruited suppressive MDSCs in a 
CXCL5/CXCR2 dependent manner and γδT17 could also induce additional suppressive 
activity from the recruited MDSCs (2014).  Using ovarian cancer as their model, Rei et 
al. showed tumor challenge induced the proliferation of γδT17 cells and this caused 
recruitment and increase pro-tumorigenic activity from small peritoneal macrophages 
(SPMs) (2014).   However, in lung cancer challenge, using IV injection, γδT17 have been 
shown to be protective in mice.  By decreasing levels of IL-6 and IL-23, Cheng et al. 
found that γδT17 cells are defective resulting in increased susceptibility to tumor foci 
development (2014).  By supplementing and reconstituting γδT17 cells they were able to 
decrease the number of tumor foci.  These studies show that γδT17 cells are in general 
indicators of increased cancer progression and worst prognosis because of their ability to 
attract immunosuppressive populations into the tumor microenvironment; however, as 
with everything there are exceptions.  
γδT17 in Autoimmune disease 
γδT17 have also been shown by our group as well as others to play a major role in the 
promotion of certain autoimmune diseases including psoriasis, EAE, collagen induced 
arthritis and EA uveitis.  In Immunity 2011, we showed that a new subset of T cells called 
dermal γδT cells were pathogenic in the progression of psoriasis through TLR7-
dependent recruitment of neutrophils to the psoriatic plaques (Cai et al., 2011).  Becher et 
al. showed the role of γδT17 in psoriasis nicely in their Nature Medicine review (Figure 
8) (2012).     
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In 2014, we showed that Vγ6 as well as Vγ4 can contribute to the pathogenic role of 
γδT17 cells in psoriasis and that the two subsets have differential development programs 
between egress of thymus and establishment in epithelial tissue (Cai et al., 2014).  
Petermann et al. found using an EAE model that γδT17 cells influence other T cell 
subsets by making them refractory to suppressive activity and preventing the induction of 
Tregs in the periphery (2010).  It was also found that γδT17 cells in EAE can promote IL-
17 production from Th17 cells thus amplifying their response (Sutton et al., 2009).  
Intradermal injection of CFA with collagen was also found to induce γδT17 responses 
and promote the development of collagen-induced arthritis again through support of Th17 
responses at the joints (Roark et al., 2013).  Liang et al. found that γδT17 that are slightly 
activated express higher levels of IL-23r and are the cells responsible for promoting 
autoimmune driving Th17 cells.  Highly activated γδT17 cells don’t express IL-23r 
therefore there is a fine balance in activation and functionality in γδT17 (2013). 
 
Figure 9. Role of γδT17 in psoriasis development. (Becher and Pantelyushin, 2012) 
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γδT17 and Microbiota 
Having both γδT17 and Th17 cells seems redundant however they are capable of 
producing IL-17 at different phases of the immune response; therefore, they each fill their 
own niche.  γδT17 can produce IL-
17 much quicker than Th17 cells 
and will be directors of the 
immune response long before 
antigen-specific Th17 cells realize 
a pathogen invasion or injury has 
occurred (Figure 10) (Roark et al., 
2008).   
γδT cells that are positive for surface marker chemokine receptor CCR6
+
, which are IL-
17 capable γδT cells, have different PPAR receptors on their surface compared to CD27
+
 
γδT cells which are IFN-γ capable (Martin et al., 2009).  CCR6
+
 γδT cells express TLR1, 
TLR2 and Dectin-1 exclusively while CD27
+
 γδT cells express TLR4.  Martin et al. show 
that different γδT cells respond differently to different types of microbes.  This is 
consistent with what we know about the location and function of these T cells.  γδT17 
cells are located near the periphery where the environment-host interface occurs.  TLR1 
recognizes lipoproteins and unconventional LPS expressed on bacteria.  TLR2 interacts 
with peptidoglycan and zymosan therefore they specialize in bacterial and fungal 
interaction.  Dectin-1 identifies β-glucan and carbohydrates specific for fungal cell walls 
therefore fungal recognition is priority.  Duan et al. found that IL-1r
+
 γδT17 in the gut 
responded to bacteroides differences through not TLR signaling but guanine nucleotide 
Figure 10. γδT17 response time and potency compared  
to Th17 response. 
 (Roark et al., 2008) 
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exchange factor VAV1 (2010). These studies are advancing our knowledge of how 
complex γδT17 cells are with varied capabilities in responding to microbiota populations.    
Our knowledge of γδT17 interaction with microbiota or microbial pathogens remains for 
the most part uncertain except to say that they are innate immune cells responding to 
microbes using the conventional methods of pattern recognition and cytokine induction.  
How γδT17 cells interact with microbiota under homeostatic conditions and the role they 
play in shaping the “microbiota” has yet to be investigated.  It is still known whether 
microbiota play a role in regulating γδT17 cells as well. More investigation is necessary 
into the regulatory mechanisms at the epithelial interface between microbiota and the 
immune system especially looking at γδT17 cells. 
Dendritic Cells and Microbiota 
Dendritic cell (DC) interaction with commensal microbiota has been thoroughly 
investigated in the GI tract showing that DCs play a critical role for maintaining the 
microbiota 
populations through 
induction of the 
adaptive immune 
response. DCs 
sample bacterial 
products at the 
epithelial surface 
using their dendrites 
Figure 11. SFB Induced Protection against Entamoeba histolytica 
Initiated Colitis through DC polarization of Th17 cells. (Burgess et al., 2014) 
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and in the peyer patches activate B cells to produce an appropriate amount of IgA 
necessary to maintain microbiota populations at equilibrium (Macpherson and Uhr, 
2004).  Goto et al. investigating the regulation of Th17 cells in murine gut showed that 
segmented filamentous bacteria (SFB) engulfed and presented by intestinal dendritic cells 
requires MHC Class II expression and is essential for Th17 maintenance (2014).  Burgess 
et al. found that SFB activation of DC can lead to protection against colitis initiated 
through Entamoeba histolytica infection (Figure 11) (Burgess et al., 2014).   Microbiota 
or pathogens that escape the initial DC barrier at the epithelial surface has been shown to 
stimulate and induce the differentiation of monocytes into DCs capable of classical DC 
antigen presentation (Cheong et al., 2010). 
Dendritic cells and γδT17 
cells 
Dendritic cells are known to 
induce IL-17 responses from 
γδT17 cells through the 
production of IL-1β and IL-23 
(Cai et al., 2011; Sutton et al., 
2009; Wu et al., 2014).    
Besides these two conventional 
cytokines, dendritic cells 
activated through 
anaphylatoxin C5a produces 
Figure 12. DC Heterogeneity, Location and Frequency in Mice 
(Manz, 2009)  
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IL-6 and TGF-β that were capable of inducing IL-17 responses from peritoneum γδT17 
cells (Xu et al., 2010).  In humans, it was shown that DCs can use antigen presentation 
using MHC like molecules CD1b and CD1c to induce γδT17 responses through the 
presentation and recognition of lipid A (Cui et al., 2009).  Studies investigating the 
activation of γδT17 cells from DCs to this point have focused primarily on the origin of 
the cytokines stimulating γδT17 cells for mechanistic purposes therefore less focus has 
been placed on what particular subsets of DCs are capable of inducing γδT17 responses.  
This is important because DCs are heterogeneous in terms of their location and effector 
function (Figure 12); therefore, it is probable that only certain types of DC types and 
responses can in fact induce a specific γδT17 response under certain conditions (Manz, 
2009). 
CD103
+
 DCs at the host-environment interface 
CD103
+
 DCs is a specific DC subset known to be particularly capable at migration and 
antigen presentation once activated at the epithelial surface (del Rio et al., 2010).  Rio et 
al. showed that CD103
+
 DCs in the lungs are potent at activating CD8 T cell responses 
while CD103
-
 DCs were better at activating CD4 T cell response (2007).  Bedoui et al. 
showed that langerin-positive CD103
+
 DCs and no other DCs in the skin are specifically 
capable of processing viral and self-antigens and presenting through cross presentation to 
CD8 T cells (2009). With close interactions to commensal microbiota populations, 
investigators have shown that CD103
+
 DCs are particularly susceptible to microbiota-
induced regulation of the immune system.  CD103
+
 DCs have been shown to be capable 
of inducing Treg induction in the absence of TGF-β unlike other CD103
-
 DC populations 
placing particular importance on this subset in immune tolerance (Coombes et al., 2007).  
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Interestingly, it was found that epithelial cells which are in close contact with CD103
+
 
DCs condition intestinal DCs in the gut to express CD103
+
 converting them to a more 
suppressive role in inducing Tregs (Iliev et al., 2009).   However showing their 
adaptability, CD103
+
CD11b
+
 DCs in the gut through TLR5 recognition of flagellin 
produce high levels of IL-23 which leads to the activation of Th22 cells and IL-22 
production (Kinnebrew et al., 2012).  IL-22 is a close relative to the IL-17 cytokine 
family normally both being secreted simultaneously by Th17 cells (Sutton et al., 2009).  
In the murine small intestine a couple of studies have shown that CD103
+
 DCs producing 
IL-6 and TGF-β are capable of regulating Th17 cells.  Located at the same epithelial 
surfaces as γδT17 cells CD103
+
 DCs could play an important role in the activation and 
expansion of γδT17 cells especially under homeostatic conditions where microbiota 
signals play such a critical role in the maintenance of innate immune cells. 
 
RATIONALE, SIGNIFICANCE AND MAIN FINDINGS 
γδT17 cells in various disease settings have been shown to either be a subset necessary 
for healthy recovery from wounds and infections or an inflammatory subset driving the 
immune response out-of-control leading to disease initiation and progression.  Our 
elementary understanding of this subset in the disease setting is based on our 
conventional thinking that these professional IL-17 producers are sentinels of the innate 
immune response.  Sentinels however require much more subtle regulation in times of 
peace in order to not cause undue damage and catastrophe.  During homeostasis they 
must learn and grow so they’ll be even more prepared for future incidences such as 
infection or injury.  New therapies have been introduced such as neutralizing IL-17 or IL-
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17r blocking antibodies which is the primary effector cytokine of this important subset.  
However, little is known about how this will effect the γδT17 cell population and our 
ability to recover from injury or fight off pathogen infection.  How γδT17 cells at the 
epithelial border are regulated during homeostasis and whether they require signals from 
the environment including 1) autocrine IL-17 signaling, 2) cellular interaction with other 
immune cells and 3) signals from the steady-state host microbiota or “microbiota” is not 
known.  Knowing how γδT17 cells are regulated should be a priority considering how 
important they are becoming in many inflammation-driven diseases and also the 
introduction of new immunotherapies specifically targeting the effector functions of 
γδT17 cells.  We demonstrate in this study that IL-17 signaling is important in the 
intrinsic and extrinsic regulation of γδT17 cells proliferation and activation.  We first 
show that γδT17 cells are drastically expanded in the absence of IL-17 signaling.  Second 
we show that the BTLA-RORγt pathway contributes the intrinsic regulation of γδT17 
cells.  Third, we demonstrate that oral microbiota activated CD103
+
 DCs drive γδT17 
expansion via cell-to-cell contact.  Fourth, we show that microbiota plays a central role in 
γδT17 peripheral regulation by inducing microbiota exchange through co-housing which 
induces γδT17 expansion.  Lastly, we show that absence of microbiota in germ free mice 
leads to the collapse of the γδT17 population and by inducing a dysbiotic environment 
such as P. gingivalis infection of the oral cavity we can induce the expansion of γδT17 
cells in draining cervical lymph nodes.  These findings are the first to demonstrate that 
γδT17 cells are directly regulated through microbiota activated CD103
+
 DCs and that 
γδT17 cells are regulated through cell-to-cell contact.  These findings are the first to show 
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that the oral microbiota plays an important role in the proliferation and activation of 
γδT17 population. 
Figure 13.  Schematic showing how 
γδT17 cells are intrinsically and 
extrinsically regulated in the periphery.  
Deficiency in IL-17 leads to oral 
microbiota dysbiosis which is detected 
through antigen sampling from CD103
+
 
DCs.  Activated CD103
+
 DCs migrate to 
cLNs where they induce γδT17 
proliferation through cell-to-cell contact 
leading to systemic expansion of γδT17s 
except in the mLNs, colon and thymus.  
Intrinsically, IL-17r signaling deficiency leads to increase expression of RORgt which 
inhibits BTLA transcription.  BTLA is a suppressor of IL-7 signaling thus γδT17 respond 
more to IL-7 signaling leading to increase expansion. 
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MATERIALS AND METHODS 
Mice 
WT and IL-1r
-/-
 mice on C57BL/6 background were purchased from Jackson Laboratory 
and homebred in our SPF murine facility. Il17ra
−/−
 mice were purchased from Taconic 
(Cambridge City, IN) and have been previously described (Ye P, 2001).  WT and IL-1r
-/-
mice were homebred and housed in University of Louisville’s SPF Clinical and 
Translational Research Mouse Facilities.  Germ-Free and Specific-pathogen-free mice 
were housed and bred at University of Chicago and were kindly provided by Dr. Yang-
Xin Fu (UTMB, Galveston, TX).  P. gingivalis and sham treated WT mice were housed 
and bred in Baxter II Vivarium (University of Louisville) and were kindly provided by 
Dr. Huizhi Wang (University of Louisville).  All animals were housed and treated in 
accordance with institutional guidelines and approved by the IACUC at the University of 
Louisville. 
Preparation of single cell suspensions 
Samples from different tissues were processed for single cell suspensions. Mouse lungs 
were flushed with PBS, minced, digested with collagenase/hyaluronidase/DNAse 
digestion buffer for 45 min at 37 °C, and passed through a cell strainer to obtain a single 
cell suspension. Red blood cells (RBC) were lysed by ACK lysis buffer. Cells were then 
washed with complete RPMI. LNs and spleens were processed by meshing against a cell 
strainer using the plunger end of 5 ml syringe. RBCs were then lysed same as the lungs.  
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Colon cecum and anal verge were harvested for cell preparations.  Colon sections were 
thoroughly washed using repetitively PBS inversions in 50 mL tubes to remove all fecal 
material.  After washes colon samples were processed similar to skin tissues as described 
in (Cai et al., 2011). 
Ex vivo immunostaining and flow cytometry analysis  
Mouse CD3, CD45, CD4, γδTCR, TCRVγ1, TCRVγ4, CD27, CD11c, CD11b, CD19, 
CD80, CD86, I-A/I-E, CD103, RORγΤ, BTLA, IFN-γ and IL-17A mAbs were obtained 
from Biolegend. Mouse CCR6 mAbs were obtained from R&Dsystem. Mouse Vγ6 TCR 
antibodies were kindly provided by Dr. Tigelaar (Yale University, New Haven, CT). For 
intracellular staining of cytokines, cells were stimulated with PMA and ionomycin in the 
presence of Golgiplug (BD-Bioscience) for 5 h and stained with different cell surface 
Abs and then fixed, permeabilized using Biolegend fixation/permeabilization buffers 
followed by staining intracellularly for IL-17 and IFN-γ.  For RORγt intracellular 
staining Ebioscience FoxP3 fixation/permeabilization kit was utilized. The appropriate 
isotype control mAbs were also used. 
Carboxyfluorescein succinimidyl ester (CFSE) labeling and co-culture assay 
Single cell homogenate from LNs, spleen, lungs and bone marrow were resuspended at a 
concentration of 1x10
7
 cells per ml and incubated with CFSE (1μM) at 37 °C for 10 min. 
The reaction was then quenched by addition of ice-cold FBS. After CFSE labeling, 1x10
5
 
γδ T cells were plated per well of a 96-well plate. 1x10
4
 DCs were added. After 5 days 
the cells were harvested.  
LTBR-Ig Partial LN Depletion 
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Two pregnant IL-17r
-/-
 females ~ E13-14 were I.P. injected either with the systemic 
antagonist, mLTBR-mIgG1 (LTBR-Ig) or control monoclonal IgG1 antibody with a 
single dose of 100 μg. LTBR-Ig was kindly provided by Dr. Fu (University of Chicago, 
Chicago, IL).  6 weeks after birth the adult mice were euthanized and successful partial 
LN removal was indicated when iLNs were absent, cLNs were reduced in size and mLN 
we observed no difference. 
Neonatal Vγ6 γδT WT:IL-17r
-/-
 Reconstituted Chimerism 
D1-2 newly born IL-17r
-/-
 (CD45.2) and SJL (CD45.1) pups were euthanized by induced 
hypothermia using ice.  Thymuses were harvested and processed by meshing with 40 μm 
cell strainer.  Thymocytes were stained with CD3, γδTCR, Vγ6 and 7AAD.  Vγ6 γδT 
cells were sorted using Beckman Coulter MoFlo.  After sorted Vγ6 γδT, WT and SJL 
were mixed in 1:1 ratio which was confirmed using BD FacsCanto and FlowJo analysis.  
Adult δTCR
-/-
 mouse was euthanized using CO2 gas and bone marrow (BM) was 
harvested and processed using 40 μm cell strainer and treated with ACK lysis buffer.  3 
δTCR
-/-
 mice were irradiated using a single dose of 950 Rads for 10 minutes.  Irradiated 
mice, after resting for 5 hours, were each injected with a thymocyte/bone marrow mixture 
containing 10x10
7
 δTCR
-/-
 BM cells and 6x10
4
 SJL:4x10
4
 IL-17r
-/-
 sorted Vγ6 γδT cells.  
After 8 weeks of reconstitution, mice were euthanized using CO2 and tissues were 
harvested, stained and analyzed.  Degree of chimerism was calculated using the before 
and after reconstitution ratio of WT:IL-17r
-/-
 Vγ6 γδ T based on CD45.1 and CD45.2 
expression. 
Tissue sectioning and microscopy 
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cLNs were frozen in OCT and stored at -80°C.  Sections of approximately 7 µm were 
fixed with cold acetone for 15 min followed by 30 min of air dry. Slides were then 
blocked using 20% FBS in PBS for 1 h. Ab staining occurred overnight at 4°C in 
humidifier staining container. After 16 h staining, secondary Ab was added for 5 h at 
4°C.  For 16s rRNA fish hybridization, the slides were air dried and incubated with 
oligonucleotide probe Cy3-EUB338 (5 ng/µl). This probe (5′-GCT GCC TCC CGT AGG 
AGT-3′) is complementary to a region of the 16S rRNA, a highly conserved domain in 
Bacteria. The probe is labeled with Cy3 fluorophore at 5’ end (Integrated DNA 
Technologies, CA). The hybridization was carried out in the presence of 50 µl of 1x in 
situ hybridization buffer (Enzo) containing EUB338 probe (5 ng/µl).  A large cover slip 
was placed on the slides and carefully pressed until the hybridization solution was evenly 
distributed over the respective section and incubated for 1 hr in humidified chamber at 46 
ºC. The cover slip was carefully removed and the slides were rinsed with distilled water 
and incubated with DAPI containing anti-fade mounting media (BioMedia, CA).  The 
cover slips were fixed to the slides overnight and the slides were analyzed the following 
day. The fluorescence images were captured using Nikon A1R confocal microscope with 
appropriate lasers. 
Co-housing and antibiotics in vivo studies 
WT and IL-17r
-/- 
mice once reaching 4 weeks old were separated into either cohoused 
groups or WT alone and IL-17r
-/- 
alone control groups. The mice were cohoused for 4-5 
weeks and then were euthanized. In the antibiotics protocol, a pregnant IL-17r
-/- 
 female 
1-2 days prior to delivering pups was given fresh antibiotics water described previously 
(Rakoff-Nahoum et al., 2004) consisting of Ampicillin (1 g/L), Vancomycin (500 mg/L), 
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Neomycin Sulfate (1 g/L) [GoldBio] and Metronidazole (1 g/L) [Sigma].  The female 
was given antibiotics water till delivery and pups were maintained on antibiotics water 
till 6 weeks of age when the experiment reached the terminal timepoint. 
 
P. gingivalis Growth and Infection 
The experimental protocol was reviewed and approved by the Institutional Animal Care 
and Use Committee, University of Louisville (IACUC # 10045).  P. gingivalis ATCC 
33277 cells were grown in TSB (BD, Franklin Lakes, NJ, USA) under anaerobic 
conditions (85% N2, 10% H2, 5% CO2) at 37°C.  Porphyromonas gingivalis ATCC 
33277 was obtained from the American Type Culture Collection (Manassas, VA, USA).  
The oral microflora was suppressed in 10- to 12-week old C57BL/6 mice by 
sulfamethoxazole (800 μg/ml) and trimethoprim (400 μg/ml) (Sigma-Aldrich, St. Louis, 
MO, USA) provided ad libitum in water for 10 days.  The mice then received pure 
drinking water for 3 days followed by oral infection with 1x109 CFU of live P. gingivalis 
suspended in 100 μL of phosphate-buffered saline with 2% carboxymethylcellulose 
directly by gavage.  Infections were performed four times at 2 day intervals.  Vehicle 
control was also established.  To enumerate P. gingivalis colonization, oral samples were 
collected along the gingiva of the upper molars using a 15-cm sterile polyester-tipped 
swabs (VWR, Radnor, PA, USA) at 1, 3 and 5 weeks after the first bacterial infection.  
Total genomic DNA was purified and amplified by qPCR.  Numbers of P. gingivalis 
were calculated by comparison with a standard curve derived from known amounts of P. 
gingivalis.  Wizard Genomics DNA Purification Kit was from Promega (Madison, WI).  
SYBRTM Green Master Mix qPCR Kit was from ThermoFisher (Waltham, MA), and the 
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primer sequences of P. gingivalis 16S rDNA are: 5’-AGGAACTCCGATTGCGAAGG-
3’ (Forward) and 5’-TCGTTTACTGCGTGGACTACC-3’ (Reverse). 
 
 
A single cell gene sequencing 
Lymphocytes from adult cLNs of wildtype and IL-17r
-/- 
mice were immunostained for 
Vγ6 γδTCR then single cell sorted into 96-well plate containing 10 µl Qiagen One Step 
PCR 1x Buffer using Beckman Coulter MoFlo.  Plates were spun down at 3000 rpm for 2 
min then frozen at -20 °C immediately.  RT-PCR for Vγ6 TCR gene sequence was 
performed at Stanford University using Barcode enabled high throughput single cell TCR 
determination described previously (Wei et al., 2015). 
Fecal Transfer in vivo studies 
Adult male WT mice were give broad-spectrum antibiotics 1 week prior to fecal 
transplant.  1 hr prior to fecal transplant mice were injected IP with 3 mg of cimetidine 
HCl and 0.02 mg of sincalide to reduce gastric acid levels and enhance reconstitution.  
After 1h, mice were given 12 mg fecal transplant using oral gavage injection.  5 WT each 
were transplanted with either IL-17r
-/-
 or WT fecal samples.   Mice were treated with 1 
injection per week for 3 weeks followed by 4 weeks of rest for gut microbiota 
reconstitution. 
Oral and fecal microbiota sequencing 
The v1-v3 regions of 16s rRNA gene was amplified using 27f 
(AGAGTTTGATCCTGGCTCAG) and 534r (ATTACCGCGGCTGCTGG) primers (1 
M). The primers were anchored adaptor (adopter A: 5’ 
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CCATCTCATCCCTGCGTGTCTCCGACTCAG 3’ and adopter B: 5’ 
CCTATCCCCTGTGTGCCTTGGCAGTCTCAG 3’) and Multiplex Identifiers (MIDs; 
10 bp long). The multiplexed amplicons were gel purified and sequenced using the 454 
Jr. Sequencing platform. The 16S rRNA sequences were analyzed using QIIME (1.9.0) 
platform scripts (www.qiime.org) (Caporaso et al., 2010). The sequences were rarified at 
randomly selected 2000 sequences/sample and downstream analysis was performed. The 
microbial classification was performed using Green Genes reference database 
(gg_13_8_otus) using QIIME tools (Caporaso et al., 2010). The sequences reference 
picked into Operational Taxonomic Units (OTUs) by clustering 97% sequence similarity 
(uclust) and classified at various taxonomic ranks (phylum, order, class, family, genus, 
and species). The beta diversity principle co-ordinate plots were generated using 
phylogenetic metrics of UniFrac distances. The Unifrac metric distances were used to 
calculate the significance between two groups using ANOSIM with 999 permutations.   
Statistical Analysis.  
Results were exhibited as means ± SEM. Statistical analysis was performed using 
GraphPad Prism software. The statistical significance of differences between groups was 
determined by the Student’s t test. All data were analyzed using two-tailed tests unless 
otherwise specified, and a P value < 0.05 was considered statistically significant. 
 
RESULTS 
γδT17 cell proliferation is peripherally regulated by the presence of IL-17 signaling 
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In the absence of pro-inflammatory cytokine IL-17 signaling, we observed a drastic 
systemic expansion of total γδ T cells particularly γδT17 cells. To extensively dissect this 
phenotype, we performed ex vivo immunostaining on cell homogenate from skin, lungs, 
body LNs, spleen, colon, and thymus. We found expansion of the total γδ T cell 
population in all tissues except the thymus and colon (Figure 14A and data not shown). In 
addition, CCR6
+
CD27
-
 γδT cells, known for being capable of producing IL-17 (Haas et 
al., 2009; Ribot et al., 2009), were specifically increased (Figure 14B). In contrast, CCR6
-
CD27
+
 γδT cells, which are capable of producing IFN-γ remained unchanged or 
significantly decreased (Figure 14B). Consistent with CCR6 expression, in vitro γδT17 
cells were increased in frequency (Figure 15A) as well as IL-17 intensity on a per cell 
basis (MFI, Figure 15B). Lack of total γδT cell expansion in the thymus suggests the 
expansion was regulated peripherally not centrally. Further support for peripheral 
expansion was the observation that γδ T cell expansion did not occur in the spleens and 
lungs till two days after birth (data not shown). CD4 T cells also showed more 
polarization towards a Th17 phenotype (Figure 17A and 17B). However, the total 
percentage of CD4 T cells was not changed (Figure 16). This data shows that γδT17 cells 
are regulated by the presence of IL-17 signaling not only in the de novo synthesis of IL-
17 (Smith et al., 2008) but also in the expansion of γδT17 cells in the periphery during 
homeostasis.  
 
 
 
 
 29 
 
Figure 14. IL-17-capable γδT cells expanded in mice deficient in IL-17 signaling 
Flow cytometry studies staining homogenous tissue samples from different organs from 
IL-17r
-/-
 mice and WT mice of similar age and sex from the same facility.  
(A) Gating from the total live lymphocyte population then gated on CD3 versus 
γδTCR for total γδ T cell percentage in each tissue. Plots representative of 7-8 
experiments. **p<0.01, ***p<0.001 
(B) Gating from total γδ T cells then looking at CCR6 versus CD27 in each tissue to 
calculate CCR6
+
CD27
-
 (IL-17 capable γδ T cells) and CCR6
-
CD27
+
 (IFN-γ 
capable γδ T cells). Plots representative of 3 experiments. **p<0.01, ***p<0.001 
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Figure 15. γδT17 cells expand and IL-17 producing capability increases in mice 
deficient in IL-17 signaling 
Flow cytometry studies staining homogenous tissue samples from different organs from 
IL-17r
-/-
 mice and WT mice of similar age and sex from the same facility.  
(A) Gated on total γδ T cells stimulated with PMA/Ionomycin for 5 h to calculate IL-
17 or IFN-γ-producing γδ T cells. Figures representative of 7-8 experiments. 
**p<0.01, ***p<0.001 
(B) Gated on IL-17-producing γδ T cells from IL-17r-/- (red) and WT mice (blue) to 
compare mean fluorescence intensity (MFI) of IL-17 production level on a per 
cell basis.  Histograms representative of 7-8 experiments. *p<0.05, **p<0.01, 
***p<0.001 
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Figure 16.  No expansion in CD4 T cell population in absence of IL-17 signaling 
Flow cytometry studies staining homogenous tissue samples from different organs from 
IL-17r
-/-
 mice and WT mice of similar age and sex from the same facility.  
(A) Gating from the total live lymphocyte population then gated CD3 versus CD4 for 
total CD4 T cell percentage in each tissue. Plots representative of 7-8 
experiments.  
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Figure 17. Th17 polarization increased with deficient IL-17 signaling 
Flow cytometry studies staining homogenous tissue samples from different organs from 
IL-17r
-/-
 mice and WT mice of similar age and sex from the same facility.  
(A) Gated on total CD4 T cells stimulated with PMA/Ionomycin for 5 h to calculate 
IL-17 or IFN-γ-producing cells.  Figures representative of  7-8 experiments. 
*p<0.05, **p<0.01, ***p<0.001 
(B) Gated on total IL-17 producing CD4 T cells from WT (blue) and IL-17r-/- (red) 
mice and looking at mean fluorescence intensity (MFI) to calculate IL-17 
production on a per cell basis. Histograms representative of 7-8 experiments. 
*p<0.05, **p<0.01, ***p<0.001 
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Cervical LNs in the neck are specifically enlarged in the absence of IL-17 signaling 
with monoclonal expansion of γδT17 cells 
When harvesting tissues for ex vivo staining, we noticed in IL-17r deficient mice that 
all tissues were of the same size and absolute cell number except the cervical LN (cLNs). 
cLN weight and total cell number were tripled but not inguinal (iLNs) and mesenteric 
LNs (mLNs) (Figure 18). In addition, a specific and drastic 8-fold expansion of γδ T cells 
in the cLNs was revealed by flow cytometric analysis (Figure 19). Interestingly, the 
expanded γδ T cells had an increased expression of CD3 and γδTCR (Figure 20). 
Stimulating the total LN homogenate from the three different LN locations showed a 
higher frequency and MFI of IL-17 production in the cLNs and iLNs but not mLNs 
(Figure 21). It was previously reported that Vγ6δ1 γδ T cells have a higher expression of 
CD3 compared to other subsets (Paget et al., 2015), suggesting that a change in the γδ T 
cell composition in the LN niche might occur in the absence of IL-17 signaling. By 
investigating the compositions of γδ T cell subsets in the three different LN locations, we 
found an extreme increase of Vγ6 γδ T cells in cLN and iLNs but not in the mLNs 
(Figure 22). The cLNs showed a drastic increase of Vγ6 γδ T cells from 5% to 71%. 
Utilizing a bar code enabled high throughput ex vivo single-cell TCR sequence analysis 
to determine specific γδ TCR repertoire in the expanded cLN Vγ6 population, we found 
that approximately 95% of these γδ T cells in both wild type (WT) and IL-17r
-/- 
cLNs 
expressed a single pair of TCR sequences encoded by Vd1Dd2Jd1 and Vg6Jg1 with no N 
region diversity (Figure 23). Since Vγ6γδT17 cells are drastically increased in cLNs, we 
hypothesized that the Vγ6γδT17 cells expanded in the cLNs may be then trafficking to 
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other areas leading to a systemic expansion phenotype. We used the LN depleting fusion 
protein lymphotoxin β receptor-Ig (LTBR-Ig) to treat ~E13-14 pregnant IL-17r
-/-
 females 
to examine whether partial LN depletion and/or reduction in size would affect the 
Vγ6γδT17 expansion in the cLNs and other peripheral tissues. We found that partial 
depletion of the LNs was sufficient to abrogate gdT expansion and proliferation of the 
rare Vγ6 population in the cLNs with decreased numbers in the spleen as well (Figure 
24). No difference was observed in mLNs.  Corresponding with the decrease in the Vγ6 
population we also saw a decrease in total IL-17 responses as well as specifically a 
decrease in Vγ6 γδT17 in all tissues studies except the mLNs (Figure 25). This data 
suggests that the environment, surrounding the cLNs, is highly conducive to γδT17 cell 
expansion. Without IL-17 signaling, γδT17 homeostatic maintenance becomes 
dysregulated resulting in the specific expansion of a rare lymphatic Vγ6γδT17 subset. 
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Figure 18. cLNs in the neck are specifically enlarged in the absence of IL-17 
signaling  
(A)  Photograph showing the difference in size (scale shown in cm) of LNs between 
WT and IL-17r
-/-
 mice from three different locations with corresponding weight 
and total cell count from each LN. Plots representative of 3 different experiments. 
*p<0.05, **p<0.01 
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Figure 19. γδT cells specifically expand in the cLNs with less expansion in LNs 
further away and no expansion in mLNs 
(A) Flow cytometry staining for γδ TCR from corresponding LN locations in (A) to 
calculate difference in total γδ T cell % between WT and IL-17r
-/-
 mice. 
Representative of 4-5 experiments. *p<0.05, **p<0.01 
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Figure 20. Expanded γδT cells in cLNs and iLNs express higher levels of CD3 and 
γδTCR 
(A) Gated on total γδ T cells in the different LN locations and analyzed for CD3 and 
γδTCR surface expression intensity using MFI. Representative of 3 experiments. 
**p<0.01, ***p<0.001 
 
 
 
 
 
 
 
 
 38 
 
 
 
 
 
 
 
Figure 21. γδT17 cells expand most in the cLNs with less expansion in LNs further 
away and γδT17 cells show increase IL-17 production per cell 
(A) Gated on total γδ T cells after 5 h PMA/Ionomycin stimulation to analyze γδT17 
frequencies. **p<0.01, ***p<0.001 
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Figure 22. The Rare LN population Vγ6 γδT17 cells are specifically expanded in 
cLNs with less expansion in LNs further away and no expansion in mLNs 
(A) Frequencies of the three subsets of γδT cells Vγ6 (Blue), Vγ1 (green) and Vγ4 
(red). Pie charts representative of three different experiments. 
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Figure 23. Monoclonal Expansion of the highly invariant  6G7 clone of Vγ6 γδT17 
cells in cLNs 
(A) Deep sequencing of individual clonal γδTCR expression on the Vγ6 γδ T cells 
sorted from cLNs of WT and IL-17r
-/-
 mice. Pie charts are representative of 192 
clones from WT and 192 clones from IL-17r
-/-
. 
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Figure 24. Partial LN depletion with LTBR-Ig decreases expansion of Vγ6 γδT in 
cLN and spleen but not mLN 
LTBR-Ig depleting protein was injected I.P. into D20 post-conception pregnant mice 
which results in partial depletion of some lymph nodes (Inguinal) and reduction in size of 
other LNs (Cervical/Mesenteric) in 6-8 week old adult mice. 
(A) Gating from total lymphocyte population then gated CD3 vs. γδTCR to analyze 
total γδ T %.  Representative of 2 experiments.  **p<0.01. 
(B) Gating from total γδ T population (A) then gated for Vγ6 γδ T %.  Representative 
of 2 experiments.  *p<0.05, **p<0.01 
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Figure 25. Partial LN depletion with LTBR-Ig decreases expansion of Vγ6 γδT17 in 
cLN and spleen but not mLN 
LTBR-Ig depleting protein was injected I.P. into D20 post-conception pregnant mice 
which results in partial depletion of some lymph nodes (Inguinal) and reduction in size of 
other LNs (Cervical/Mesenteric) in 6-8 week old adult mice. 
(A) Gating on total lymphocyte population then gated for IL-17 and IFN-γ-producing 
cells.  Representative of 2 experiments. **p<0.01, ***p<0.001 
(B) Gating from total Vγ6 γδ T population (B) then gated for IL-17-producing Vγ6 
γδT cell %.  Representative of 2 experiments.  *p<0.01, ***p<0.001 
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Deficiency in IL-17r signaling leads to upregulation of RORγτ, suppression of 
BTLA and expansion of IL-17
+
 γδ T cells in some but not all tissues 
IL-7 has been shown to specifically expand γδT17 cells in mice and humans and B- 
and T- lymphocyte attenuator (BTLA) directly regulates γδ T cell expansion through 
suppression of IL-7 signaling (Bekiaris et al., 2013; Michel et al., 2012). The master 
transcriptional regulator of IL-17 production, RORγτ, inhibits the transcription of BTLA. 
We thus hypothesized that lack of IL-17 signaling through its receptor would increase IL-
17 mRNA levels by increased levels of RORγt thus decreasing BTLA regulation of IL-7 
signaling. Indeed, we found increased RORγt in IL-17r
-/-
 CD27
-
γδT cells from cLNs and 
iLNs (Figure 26).  Knowing that RORγτ inhibits the transcription of BTLA, we stained 
for extracellular surface expression of BTLA and found a decrease in expression (Figure 
27).  An increase in RORγτ and a decrease in BTLA levels suggest a decrease inhibition 
of IL-7 signaling leading to a γδT17 specific expansion. However, IL-7r expression on 
γδT cells or levels of IL-7 mRNA in various tissues in the absence of IL-17 signaling was 
comparable with WT mice (data not shown). To investigate whether decreased 
expression of BTLA would lead to intrinsic expansion of IL-17r
-/- 
Vγ6 γδ T cells over 
WT Vγ6 γδ T cells, we irradiated δTCR
-/- 
 mice and reconstituted their γδT cells with a 
1:1 ratio of IL-17r
-/- 
 and WT Vγ6 γδ T cells from neonatal thymocytes. Eight weeks after 
reconstitution, the data suggested a slight advantage of IL-17r
-/- 
 γδ T cells but only in 
certain tissues such as LNs and spleen but not in the skin and lungs (Figure 28).  
Interestingly, this intrinsic advantage was seen strongest in the cLNs specifically but only 
in total γδ T cells and not γδT17 frequency.  If gating on total Vγ6 γδT cells the 
percentage is similar between WT and IL-17r
-/-
 (data not shown) since this population is 
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centrally preprogrammed in the thymus produce IL-17 so in this case it is more accurate 
to look at the total Vγ6  rather than more specifically the IL-17 producing in order to 
determine any intrinsic advantage after reconstitution.  These data suggest that γδT17 cell 
expansion is partly regulated by the presence of IL-17R signaling through the intrinsic 
RORγt-BTLA regulatory pathway. However, this modest intrinsic defect advantage does 
not explain a monoclonal expansion of Vγ6 γδT17 cells in all peripheral tissues besides 
the thymus, colon and mLNs with a specific and drastic expansion noted in the cLNs. 
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Figure 26. IL-17r
-/-
 CD27
-
 γδT17 cells have increased RORγt expression level.   
(A)  Gated on total CD27- γδT from IL-17r-/- (red) and WT (blue) then analyzing for 
% and MFI of RORγt.  Representative of 3 experiments.  *p<0.05, **p<0.01, 
***p<0.001 
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Figure 27. IL-17r
-/-
 CD27
-
 γδT17 cells have decreased BTLA expression.  
(A) Gated on total CD27- γδT from IL-17r-/- (red) and WT (blue) then analyzing for % 
and MFI of BTLA.  Representative of 3 experiments.  *p<0.05, **p<0.01, 
***p<0.001 
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Figure 28. Neonatal IL-17
-/- 
Vγ6 γδT from thymocytes show some reconstitutive 
advantage over their WT counterparts particularly in the spleen and LNs. 
(A) Diagram of the neonatal thymocyte and adult BM reconstitution protocol implemented. 
Thymic Vγ6 γδT cells from neonatal WT SJL (CD45.1) and IL-17r
-/-
 mice were mixed at 
1:1 ratio and then adoptively transferred along with BM cells from Tcrd
-/-
 mice into 
lethally irradiated Tcrd
-/-
 recipient mice. Mice were reconstituted for 8 weeks and tissues 
from the lungs, skin, spleen, body LN, and cLN were harvested and stimulated with 
PMA/ionomycin. Total γδT cells and γδT17 cells from WT or IL-17r
-/-
 were 
differentiated using congenic markers CD45.1 versus CD45.2. The bar graphs, combined 
data from 2 experiments with 3 mice each, show the degree of chimerism in the lungs, 
skin, spleen, body LNs (all LNs except cLN and mLN) and cLNs. Degree of chimerism 
was calculated using the before and after reconstitution ratio of WT:IL-17r
-/-
 Vγ6 γδ T. 
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γδT17 cells expand due to DC-dependent proliferation 
Different mechanisms could lead to a population’s expansion such as increased 
survival, less apoptosis or proliferation. We searched to find in what way the Vγ6 γδ T 
cells were expanding especially in the cLNs where the phenotype was most prominent. 
Ex vivo immunostaining for the proliferation protein Ki-67 confirmed specific and 
significant proliferation in CD27
-
CCR6
+
 γδ T cells (Figure 29).  These are drastic 
changes considering in WT mice the predominant γδT proliferative cells were 
CD27
+
CCR6
-
 γδT cells.  A previous study showed that IL-7 specifically drives γδT17 
expansion in the LNs (Michel et al., 2012). Therefore we examined whether γδT17 in IL-
17r
-/- 
LNs responded more to IL-7 stimulation. Surprisingly, we observed that using 
whole cells from IL-17r
-/- 
mice after 5 days of culture led to spontaneous endogenous 
proliferation of γδ T cells without any stimulation, mainly γδT17 cells (Figure 30). 
Accounting for the endogenous proliferation, we did not see an advantage of γδT17 from 
IL-17r
-/- 
mice over WT when stimulated with LPS or IL-7.   LPS was used as a control 
because its been shown that CD27
+
 (IFN-γ capable) γδT cells express TLR4 
preferentially while CCR6
+
 (IL-17 capable) γδT cells express other receptors such as IL-
7r, TLR2, and dectin-1 (Martin et al. 2009).  Our data supports Martin et al’s conclusions 
showing that LPS indeed induces the proliferation of IL-17
-
 γδT cells with much higher 
IL-17
-
 γδT proliferation shown in the WT mice due to the higher frequency of CD27
+
 γδT 
cells.  Endogenous proliferation was not observed in other tissues such as lungs, spleen or 
bone marrow (Figure 31).  It was also noted that γδT cell percentage in the bone marrow 
was very low similar to WT again confirming that γδT17 regulation through IL-17 
signaling is peripheral and not centrally regulated either in the thymus or bone marrow. 
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This in vitro spontaneous proliferation system allowed us to specifically identify the 
mechanism of γδT17 proliferation. Endothelial cells have been shown to be the major 
producers of IL-7 (Iolyeva et al., 2013). However, by sorting out CD45
- 
cells from total 
cLN homogenate then culturing for 5 days, we observed no difference in proliferation of 
γδT17 cells in vitro (Figure 32). We have previously shown that DCs are important 
inducers of γδT17 proliferation through the production of IL-1β/IL-23 (Cai et al., 2011; 
Wu et al., 2014). Therefore, we next examined whether γδ T proliferation in this system 
was dependent on DCs. Indeed, by depleting CD11c
+
 DCs, γδT17 cell proliferation was 
significantly reduced and when adding DCs back we restored γδT17 proliferation (Figure 
33). Next, we examined γδ T cell and DC interaction in situ in the IL-17r
-/-
 cLNs using 
immunofluorescence and confocal microscopy. We saw increased total γδ T cells as well 
as CD11c
+
 DCs validating our flow cytometry findings. At lower magnification we did 
see increased co-localization between γδ T cells and DCs not seen in the WT control 
cLNs. At higher magnification in the IL-17r
-/-
 cLNs, close and intimate interactions 
between γδ T cells and DCs were readily seen (Figure 34). Thus, DCs from cLNs may 
directly interact and induce γδT17 proliferation and expansion.   
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Figure 29. Expansion of γδT population in the lack of IL-17 signaling is due to cell 
proliferation 
(A) Ex vivo staining of WT and IL-17r-/- cLN cells for proliferation marker, Ki-67, to 
calculate total proliferating cells and contribution of γδ T and specifically 
CCR6
+
CD27
-
 γδ T to proliferation. Representative of 2-3 experiments. *p<0.05, 
***p<0.001 
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Figure 30. Endogenous proliferation of γδT17 cells in the absence of IL-17r in vitro 
(A) CFSE in vitro assay with no stimulation, LPS stimulation and IL-7 titrated 
stimulation of total cLN cells from WT and IL-17r
-/- 
mice for 5 days then re-
stimulated for 5 h with PMA/Ionomycin to examine proliferation of γδT17. Gated 
on total γδ T cells. Dot plots and histograms representative of 5 experiments.  
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Figure 31. Endogenous proliferation of γδT17 as seen in only the LNs and not other 
tissues. 
(A) Gating on total live lymphocyte population in different tissues then gated on total γδT 
cells to analyze the γδT17 proliferation using IL-17 vs CFSE.  Representative of 2-3 
experiments. 
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Figure 32. Endogenous proliferation of γδT17 is independent of CD45
-
 cells 
(A) Depleted CD45- cells from IL-17r-/- LNs using FacsAria to access CD45- cell 
contribution to endogenous proliferation after CFSE labeling and 5 days culture. 
Representative of 3 experiments.  
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Figure 33. γδT17 cells expand due to DC-dependent proliferation 
(A) Depletion of CD11c+ cells from IL-17r-/- cLNs or adding back of CD11c+ cells to 
examine γδT cell proliferation after 5 days culture. Cells were gated on 7AAD
-
CD3
+
γδTCR
+
 cells. Representative of 5 experiments. *p<0.05, **p<0.01 
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Figure 34. γδT and DC expanded and co-localized in situ with close interaction of 
two populations 
(A) Immunohistochemistry staining of WT and IL-17r-/- cLNs with pan-γδTCR 
(green), CD11c (red) and DAPI (blue) to visually show increase in γδ T cells and 
DCs (left) and to show γδ T cell and DC interaction in situ in IL17r
-/-
 cLNs 
(right). Representative of cLNs from 3 different mice. Scale bar: 20 μm. 
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CD103
+
 DCs specifically induce Vγ6 γδT17 cell proliferation 
DCs in LNs are composed of various subsets with different functions. We noticed that 
in cLNs CD103
+
 DCs (CD11b
lo
CD11c
hi
CD103
hi
) were increased in frequency within 
total CD11c
+
 DCs (Figure 35).  Not only was frequency increased but the side-scatter 
(SSC) for IL-17r
-/-
 CD103
+
 DCs was increased which is correlative with increased 
activation (Crawford et al., 2003). The increased CD103
+
 DCs were in fact more 
activated with upregulated CD80 and CD86 expression levels but not MHC class II 
(Figure 36).  cLNs in the IL-17r
-/-
 mice under H&E show hypertrophy and germinal 
center reactivity suggesting there might be bacterial activation of the immune system 
(Figure 37). To determine whether these DCs could be activated by bacterial Ags, we 
utilized 16s rRNA FISH hybridization and confocal microscopy to probe for bacterial 16s 
rRNA in the cLNs. The enlarged IL-17r
-/- 
cLNs showed a drastic increase in the presence 
of 16s rRNA compared to WT counterparts, suggesting that CD103
+
 DC activation could 
be due to bacterial product exposure (Figure 38).  
To investigate whether CD103
+
DCs drive γδT17 cell proliferation, we depleted this 
subset from whole cLN and cultured the cells without stimulation for 5 days. γδT17 cell 
proliferation was reduced by 75% after CD103
+
DCs depletion and restored by adding 
back CD103
+
 DCs to culture (Figure 39). In addition, IL-1β Ab blockade did not reduce 
γδT17 proliferation. To further determine whether γδT17 expansion can be induced by 
cLN CD103
+
DCs, WT γδ T cells were co-cultured with different DC populations 
including CD103
+
 DCs either from cLNs or mLNs of IL-17r
-/-
 mice (Figure 40). Only 
CD103
+
 DCs from the cLNs were able to induce proliferation of the WT γδ T and this 
CFSE
low
 population being negative for Vγ4 and Vγ1 thus Vγ6
+ 
is consistent with ex vivo 
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cLN staining. Consistent with the IL-1β blockade results, γδT cell from IL-1r
-/-
 proliferate 
well when co-cultured with cLN CD103
+
 DCs (Figure 41), suggesting that γδT17 
proliferation is not dependent on IL-1r signaling. To examine whether CD103
+ 
DCs drive 
γδT17 proliferation in vitro either through cell-to-cell contact or soluble factors, WT γδ T 
cells were co-cultured with CD103
+
 DCs from IL-17r
-/- 
mice in a transwell system. The 
co-cultured γδ T cells with the CD103
+
 DCs showed strong proliferation, predominately 
Vγ6. However, when separated from the CD103
+
 DCs, the WT γδ T cells did not 
proliferate (Figure 42), suggesting that a cell-to-cell interaction between DCs, specifically 
CD103
+
DCs and γδT17 cells is required for the induction of their proliferation.  
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Figure 35. CD11c+ DCs and specifically CD103
+
 DCs expanded in cLNs  
(A)  After ex vivo staining of cLN cells and gating from total live cells, CD11c+ cells 
were gated for calculating total DCs (top) then from this population CD103
+
 DCs 
were gated (bottom). Representative of 2-3 experiments. ***p<0.001 
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Figure 36. CD103
+
 DCs in cLNs activated with increased expression of CD80 and 
CD86 
(A) Gated on total CD103+ DCs from WT and IL-17r-/- cLNs, staining of surface 
activation markers CD80, CD86 and MHC Class II was performed. Both 
percentages and MFI are shown. Representative of 2-3 experiments. *p<0.05, 
***p<0.001 
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Figure 37.  Hypertrophy and increased germinal center reactions in IL-17r
-/-
 oral 
draining cLN 
(A)   Sectioning and H&E staining was performed by the University of Louisville 
Department of Pathology.  Sections were analyzed and photographed using 
Asperio ScanScope.  Images representative of 5 cLNs from WT and IL-17r
-/-
.  
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Figure 38. 16s rRNA drastically increased in cLNs of mice lacking IL-17 signaling 
(A) 16s rRNA FISH hybridization on frozen tissue sections from WT and IL-17r-/- 
cLNs.  Probe Eub336-cy3 was used and TRIC signal intensity at random yet the 
same locations for WT and IL-17r
-/-
 cLN was used to quantify the amount of 
bacterial RNA in LNs. Representative of 3 different cLNs from 3 mice.  
***p<0.001 
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Figure 39. CD103
+
 DC depletion reduces proliferation of γδT cell in vitro 
(A) CFSE-labeled whole cLN cells were depleted of CD103+ DCs and cultured for 5 
days. In conditions of whole cLN cells depleted with CD103
+
DCs, sorted 
CD103
+
DCs were added back in the presence or absence of anti-IL-1β 
neutralizing mAb (2 μg/ml). γδT cell proliferation was shown. Cells were gated 
on 7AAD
-
CD3
+
γδTCR
+
 cells. Representative of 5 experiments. *p<0.05, 
**p<0.01, ***p<0.001. n.s., not significant 
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Figure 40. CD103
+
 DCs specifically from cLNs not mLNs induce Vγ6 γδT17 cell 
proliferation 
(A) Using MoFlo sorter, WT γδ T cells from LNs and spleens were purified and 
CFSE labeled then co-cultured with three different IL-17r
-/-
 DC populations 
(CD103
+
 cLNs, CD103
+
 mLNs, and CD103
-
 cLNs) for 5 days. Representative 
histograms of γδT cell proliferation and summarized percentages of proliferated 
cells are shown (upper panel). Representative dot plots of proliferated γδT cells 
with Vγ4/Vγ1 staining are shown (bottom panel). Cells were gated on 7AAD
-
CD3
+
γδTCR
+
 cells. Representative of three experiments. *p<0.05 
 
 
 
 
 
 64 
 
 
Figure 41. CD103+ DC induction of γδT17 proliferation is IL-1r independent 
(A) CD103+ DCs co-cultured with WT and IL-1r-/- γδ T cells (1:5) to determine the 
role of γδT IL-1r expression in the proliferation of γδT17 (left panel).  Gated on 
total γδT population and then showed total IL-17
+
 cells after 5 days co-culture.  
Gated on total γδT17 and then gated for CFSE to analyze the % of proliferated 
γδT17 from co-cultures.  Representative of 3 experiments. **p<0.01 
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Figure 42. CD103
+
 DCs induction of Vγ6 γδT17 cell proliferation is cell-to-cell 
contact dependent 
(A) 96-well transwell plate was utilized to separate CD103+ DCs from cLNs of IL-
17r
-/-
 mice from WT γδ T cells to determine if cell-to-cell contact is required. 
Representative histograms of γδT cell proliferation and summarized percentages 
of proliferated cells are shown (upper panel). Representative dot plots of 
proliferated γδT cells with Vγ4/Vγ1 staining and summarized data are shown 
(bottom panel). Cells were gated on 7AAD
-
CD3
+
γδTCR
+
 cells. Representative of 
3 experiments. ***p<0.001 
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Oral but not gut microbiota influences the expansion of γδT17 cells in the draining 
cLNs 
Previous studies have shown an important role for microbiota in the expansion of 
γδT17 cells during various disease settings (Cheng et al., 2014; Duan et al., 2010; Wu et 
al., 2014). In the gut, the increase of SFB leads to increased frequency of Th17 cells 
(Goto et al., 2014). The 16s rRNA gene sequencing data of fecal gut microbiota indeed 
showed that WT and IL-17r
-/-
 mice have distinct gut microbiota (Figure 43). In addition, 
IL-17r
-/-
 mice had increased SFB in the gut that correlated with increased Th17 cells in 
the lamina propria of the colon (Figure 43). However, we did not see a difference in γδ 
%, Vγ usage composition or an increased γδT17 cells in the colon (Figure 44). To further 
examine the effect of gut microbiota on γδT17 cells, we transferred fecal samples from 
IL-17r
-/-
 mice to WT mice via gavage needle injection to avoid any oral cavity 
contamination. However, we did not observe γδT or Vγ6  γδT expansion in the WT mice 
transplanted with IL-17r
-/-
 gut microbiota (Figure 45).  Staining for CCR6 and CD27 we 
were able to determine that IL-17-capable (CCR6+CD27-) γδT cells were not expanded 
as well as CCR6+ (chemokine specific for IL-17 producing Th17 cells) CD4 T cells 
(Figure 46).  Even though not significant we observed an increasing trend in CCR6
+
 CD4 
T cells in the colon LP after transfer with IL-17r
-/-
 fecal transplant which is consistent 
with increased Th17 in the colon (Figure 44) most likely due to increase SFB levels in 
IL-17r
-/-
 gut microbiota (Figure 43). 
Considering the drastic phenotype in the cLNs and the increase in migratory CD103
+
 
DCs and bacterial products there, we investigated the effect of oral microbiota on γδT17 
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cell regulation. Unlike the gut microbiota composition, the overall oral microbiota 
composition at phylum and genus levels was significantly altered in IL-17r
-/-
 mice 
compared to WT (Figure 47). Specifically, Lactobacillus genus  (Firmicutes phylum) 
were significantly increased in IL-17r
-/-
 mice compared to WT. In contrast, 
Aggregatibacter genus was significantly decreased in IL-17r
-/-
 mice. The statistical 
analysis of these distance matrices was performed using ANOSIM test with 999 
permutations. The results demonstrated that both weighted and unweighted UniFrac 
distances were significantly different compared to each other indicating definitive 
differential microbiota composition between WT and IL-17r
-/-
 mice. We next utilized 
broad spectrum antibiotic treatment (ampicillin, neomycin, vancomycin and 
metronidazole) from prior to birth all the way to 6 weeks old to determine whether γδT17 
expansion could be abrogated. Treatment with the oral antibiotic regimen prevented the 
increase in size and absolute cell number of the cLNs but did not affect the size and 
absolute number of cells in other LNs (Figure 48). γδ T cell %, Vγ6 % and γδT17 % and 
absolute numbers were all decreased in the cLNs (Figure 49) as well as other peripheral 
tissues including the spleen and lungs but importantly not in the colon (Figure 50). 
Together these data suggest that microbiota in the oral cavity and not the colon play an 
important role in the monoclonal proliferation of Vγ6 γδT17 cells leading to systemic 
expansion of γδT17 cells.  
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Figure 43. Gut microbiota composition is different in the absence of IL-17 signaling 
(A)  Bacterial genomic DNA was extracted from the fecal droppings of 15 WT and 15 
IL-17r
-/-
 then using deep sequencing to analyze for differences in microbiota 
populations.  RT-PCR was used in order to confirm SFB and Bacteroides 
findings. *p<0.05, **p<0.01 
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Figure 44. Differences in gut microbiota in IL-17r
-/-
 mice does not lead to a 
difference in lamina propria γδ T populations but does lead to increase in Th17 
responses. 
(A)  Gated on total live CD45+ cells in the lamina propria of the colon after tissue 
processing and cell homogenization. From live CD45
+
 cells gated CD3 vs γδTCR 
to analyze γδT % and αβ T %.  From these two populations gated further looking 
at Vγ expression of Vγ4 and Vγ6 in γδ % population as well as IL-17
+
 cells in the 
γδT and αβ T populations.  5 h PMA/I stimulation was used to look at IL-17 
responses.  Representative of 3 experiments.  *p<0.05 
 
 
 70 
 
 
Figure 45. Fecal transfer from IL-17r
-/-
 mice to WT mice does not induce γδT or 
Vγ6 expansion 
Gastric gavage needle injection was used to do 3 times treatment of 12 mg IL-17r
-/-
 or 
WT fecal matter to 10 WT mice in order to determine whether IL-17r
-/-
 gut microbiota 
directly induces a change in γδT populations and γδT17 expansion.  
(A) Gating on total live lymphocyte population and then gated on CD3 vs. γδTCR 
to quantify γδ T %. *p<0.05, **p<0.01.   
(B) Gating on the total γδT population and then gated for Vγ6+ %.   
(C) Gating on total γδT cells and then gated for CD27 vs CCR6+ in order to 
analyze the CCR6
+
CD27
-
 potential γδT17 %.  
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Figure 46. Fecal transfer from IL-17r
-/-
 mice to WT mice does not induce 
CCR6
+
CD27
-
 γδT cells or CCR6
+
 CD4 T cells 
Gastric gavage needle injection was used to do 3 times treatment of 12 mg IL-17r
-/-
 or 
WT fecal matter to 10 WT mice in order to determine whether IL-17r
-/-
 gut microbiota 
directly induces a change in γδT populations and γδT17 expansion.  
(A) Gating on total γδT cells and then gated for CD27 vs CCR6+ in order to 
analyze the CCR6
+
CD27
-
 potential γδT17 %.  
(B) Gating on total CD4 and then gated for CCR6+ in order to analyze the CCR6+ 
(critical Th17 chemokine receptor) CD4 %. 
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Figure 47. Oral Microbiota is different in the lack of IL-17 signaling 
(A) The oral microbiota from WT and IL-17r-/- mice was analyzed by sequencing 16s 
rRNA gene (v1-v3 region) and analyzed using QIIME 1.9.0 software platform. 
The abundant phylum and genus distribution between WT and IL-17r
-/-
 suggest 
alterations in the microbial composition. Principle coordinate analysis of 
unweighted UniFrac distance matrix showing the distinct clusters for WT (blue) 
and IL-17r
-/-
 (red) mice. ** p<0.001; *** p<0.0001 
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Figure 48. Oral Broad Spectrum Antibiotics reduces the size of cLNs specifically 
(A) cLNs (upper) and iLNs (lower) after oral antibiotics treatment for 6 weeks along 
with the corresponding weight of each node and the total cell number from that 
LNs.  Representative of 2-3 experiments. ***p<0.001 
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Figure 49. Oral Broad Spectrum Antibiotics Lead to Drastic Decrease in Vγ6  γδT17 
population in the cLNs 
(A) Flow cytometry analysis showing percentages of γδ T cells, αβT cells, Vγ6 γδ T 
cells and IL-17-producing γδ T and αβ T cells in the cLNs after 6 week oral 
antibiotics treatment from 1-2 days prior to birth to 6 weeks of age. 
Representative of 2-3 experiments. *p<0.05, **p<0.01, ***p<0.001 
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Figure 50. Oral Broad Spectrum Antibiotics Lead to Drastic Decrease in Vγ6  γδT17 
population in the lungs and spleen but not the colon 
(A) Flow cytometry analysis showing percentages of γδ T cells, Vγ6 γδ T cells, 
γδT17, and Th17 in the lungs, spleen and colon (lamina propria) after 6 week oral 
antibiotics treatment from 1-2 days prior to birth to 6 weeks of age. 
Representative of 2-3 experiments. *p<0.05, **p<0.01, ***p<0.001 
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Microbiota exchange induces the proliferation of γδT17 cells in the cLNs and 
systemic expansion of γδT17 cells 
To examine the influence of microbiota on the peripheral regulation of γδT17 cells, 
without affecting the development of mucosal immunity, we cohoused animals together 
(Kabat et al., 2014; McDermott and Huffnagle, 2014). WT mice were cohoused with IL-
17r
-/- 
mice for 10 weeks after weaning. Co-housing resulted in expansion of T cells, γδT 
cells and Vγ6
+
 γδT cells in the cLNs, skin and lungs (Figure 51). After stimulation, an 
observed increase in γδT17 and Vγ6
+
 γδT17 cells was also seen (Figure 52). Conferral of 
γδT17 expansion by microbiota exchange was strongest in the cLNs and skin which also 
resulted in a significant increase in γδT17 cells in the spleen. This finding suggests that 
oral microbiota can in fact induce the specific induction of Vγ6 γδT17 systemic 
expansion. Th17 cells were also increased in the skin and LNs however not in the spleen 
(Figure 53) again suggesting that the phenotype of systemic expansion is γδT17 specific. 
As previously shown that microbiota led to increased expression of surface activation 
markers on CD103
+
 DCs (Figure 36), CD103
+
 DCs from cohoused WT mice showed 
increased levels of activation in cLNs with increased frequency and expression of CD80 
and CD86 (Figure 54) although frequencies of CD11c
+
 or CD103
+
 DCs were not altered. 
These data indicate that microbiota under homeostatic conditions do in fact modulate the 
proliferation and expansion of γδT17 cells.    
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Figure 51. Cohousing of IL-17r
-/-
 mice with WT mice increases CD3
+
 T cells and 
specifically expands Vγ6 γδT cells in cLNs, spleen and skin 
(A)  Flow cytometry analysis of cell homogenate from different tissues examining the 
surface marker percentages of CD3, γδ T cells and Vγ6 γδ T cells between control 
and cohoused WT mice with IL-17r
-/-
 mice of the same age and sex. 
Representative dot plots and summarized data showing percentages of total CD3+ 
T cells, γδT cells, Vγ6 T cells. *p<0.05, **p<0.01 ***p<0.001 
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Figure 52. Cohousing of IL-17r
-/-
 mice with WT mice induces the proliferation of 
γδT17 cells in the cLNs and systemic expansion of γδT17 cells in WT mice 
(A)  Flow cytometry analysis of cell homogenate from different tissues examining the 
intracellular IL-17 expression between control and cohoused WT mice with IL-
17r
-/-
 mice of the same age and sex. Representative dot plots and summarized data 
showing percentages of total γδT17 cells as well as IL-17-producing Vγ6 T cells 
are shown. *p<0.05, **p<0.01 ***p<0.001 
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Figure 53. Cohousing of IL-17r-/-  mice with WT mice leads to increase Th17 
polarization in the cLNs and skin but not in the spleen 
Flow cytometry analysis of cell homogenate from different tissues looking at the 
intracellular expression of IL-17 from CD4 T cells.  
(A) Gating on total live lymphocyte population then gated on CD3
+
CD4
+
 T cells to 
analyze Th17 responses after 5 h PMA/Ionomycin stimulation. **p<0.01, ***p<0.001 
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Figure 54. Cohousing of IL-17r
-/-
 mice with WT mice induces the activation of 
CD103
+
 DCs with increase expression of CD80 and CD86 
(A) Surface marker staining of DCs and CD103+ DCs from cLNs in control and 
cohoused WT mice. Cells were also stained with CD80, CD86 and MHC Class II. 
Representative dot plots and summarized data showing percentages of total 
CD11c
+
 DCs, CD103
+
DCs, CD80
+
CD103
+
DCs, CD86
+
CD103
+
DCs, MHC 
classII
+
CD103
+
DCs are shown. MFI of CD80, CD86, and MHC class II on 
CD103
+
DCs is also shown. *p<0.05, **p<0.01, ***p<0.001 
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Lack of oral microbiota reduces Vγ6 γδT17 population and introduction of 
dysbiosis-inducing oral pathogen PG leads to γδT17 expansion in cLNs 
 GF mice have been used extensively of late to study how immunological systems 
are function-dependent on microbiota-host interactions (Grover and Kashyap, 2014; 
Kostic et al., 2013; Yi and Li, 2012).  Using antibiotics to remove the microbiota from 
IL-17r
-/-
 mice we previously showed that γδT17 expansion beyond physiological levels in 
IL-17r
-/-
 mice was abrogated (Figure 48-50).  We also showed that dysbiotic microbiota 
transfer from IL-17r
-/-
 to WT mice induces γδT17 expansion in the oral cavity but not the 
gut (Figure 51-52).  We next investigated whether under physiological conditions in the 
absence of microbiota γδT17 population especially in the oral draining cLNs would be 
reduced.  In Figure 55A, total IL-17 producing cells in the cLNs of GF mice were 
drastically lower compared to specific-pathogen-free (SPF) mice.  Looking specifically at 
IL-17 producing γδT cells we observed a dramatic decrease in their IL-17 producing 
capabilities with a corresponding decrease in presence of Vγ6
+
 γδT cells.  
Immunostaining of dendritic cell populations showed a correlating decrease in total 
dendritic cells and CD103
+
 dendritic cells in the absence of microbiota (Figure 55B). 
 Oral pathogen PG has been used for decades in order to study the 
pathophysiology of periodontal disease; however, it has not been until recently that 
investigators have determined that periodontal disease results from PG-induced dysbiosis 
of oral microbiota (Maekawa et al., 2014; Zenobia and Hajishengallis, 2015).  Using a 
chronic PG infection model, we observed expansion of total IL-17 and γδT17 cells in the 
cLNs of PG treated mice compared to sham controls (Figure 56A).  We also observed 
increasing levels of Vγ6 γδT cells in the cLNs (Figure 56A) corresponding to increasing 
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activation of CD103
+
 DCs using activation marker CD80 and CD86 though not 
statistically significant (Figure 56B, data not shown).  IL-17 and γδT17 expansion seen in 
this model was observed specifically in the draining oral cLNs and not in other tissues 
including the bLNs, mLNs, spleen, skin, lungs and colon (data not shown). 
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Figure 55. Lack of oral microbiota reduces Vγ6 γδT17 and CD103
+
 DCs in Germ 
Free Mice 
Flow cytometry studies of immunostained homogenized cLNs from GF and SPF mice 
of similar age and sex from the same facility (U. of Chicago, Chicago, IL) 
(A) Gating from the total live cells stimulated with PMA/Ionomycin for 5 h then 
gated IL-17
+
 population (upper panel), gating from the total γδT cell then gated 
on IL-17
+
 population (middle panel) and gated on Vγ6 population (lower panel). 
**p<0.01, ***p<0.001 
(B) Gating from total live cells then gated CD11c+ population (upper panel) and 
gating from CD11c
+
 population then gated CD103
+
 population.  *p<0.05, 
**p<0.01 
SPF GF 
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Figure 56. Introduction of dysbiosis-inducing oral pathogen PG leads to γδT17 
expansion in cLNs 
Flow cytometry studies of immunostained homogenized cLNs of PG infected and sham 
treated mice of similar age and sex from the same facility (Baxter II Vivarium, University 
of Louisville, Louisville, KY).  
(A) Diagram of the PG infection protocol over 48 days.  Gating from the total live 
cells stimulated with PMA/Ionomycin for 5 h then gated IL-17
+
 population (upper 
panel), gating from the total γδT cell then gated on IL-17
+
 population (middle 
panel) and gated on Vγ6 population (lower panel).  Plots representative of 2 
experiments. *p<0.05 
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(B) Gating from total live cells then gated CD11c+ population (upper panel) and 
gating from CD11c
+
 population then gated CD103
+
 population (middle panel).  
Gating from CD103
+
 population then gated for CD80 in histogram format.  Plots 
representative of 2 experiments. 
DISCUSSION 
In this study, we demonstrate that γδT17 cells are regulated both directly through IL-
17r intrinsic feedback signaling as well as indirectly by modulating the epithelial 
microbiota which in turn regulates γδT17 frequency and IL-17 producing capabilities.  
The major regulatory pathway appears to be location and environment specific due to 
disproportionate expansion of γδT17 cells in the oral draining cLNs. We show that γδT17 
cells are regulated in the cLNs through microbiota activated CD103
+
 DCs in a cell-to-cell 
contact dependent mechanism leading to monoclonal expansion of Vγ6 γδT17.  Unlike 
conventional DC activation of γδT17 cells using IL-1β cytokine induced proliferation, the 
CD103
+
 DCs activation in this study was IL-1β and IL-1r independent. This peripheral 
regulation network is initiated at the epithelial surface and through CD103
+
 DC activation 
leads to Vγ6 γδT17 proliferation in the draining cLNs and subsequently to systemic 
expansion in tissues such as the lungs, skin and spleen but not in the colon or mLNs. 
Partial depletion of LNs resulted in less notable expansion of the γδT17 population 
systemically suggesting a watershed effect initiated at the oral draining cLNs. 
A master transcription factor in the regulation of IL-17 production by γδT17 is RORγt 
(Malhotra et al., 2013; Ribot et al., 2009). In addition, it has recently been reported that 
RORγt represses BTLA transcription while IL-7 increases the surface expression of 
BTLA on γδ T cells (Bekiaris et al., 2013). Our results suggest that IL-17r signaling 
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suppresses RORγt resulting in heightened BTLA inhibition of IL-7 signaling.  IL-7 is a 
ubiquitous survival cytokine throughout the body and as we’ve shown in our IL-7 
stimulation in vitro studies, it can induce γδT17 proliferation at very low concentrations.  
IL-17r signaling modulating the CD27
-
 γδT17 specific proliferative capability of IL-7 
would provide a key feedback regulatory system in order to maintain γδT17 cells in the 
periphery.  By reconstituting 1:1 WT and IL-17r
-/-
 Vγ6 γδ T cells, we showed some 
intrinsic constitutive advantage for IL-17r
-/-
. Interestingly, total IL-17r
-/-
 γδ T cells 
showed some advantage in cLNs and iLNs; however, there was little if no advantage for 
IL-17r
-/-
 γδT17.  With the majority of Vγ6 γδT in both IL-17r
-/-
 and WT mice producing 
IL-17 in any tissue creating such a high baseline, total Vγ6  is a better indicator of an 
intrinsic advantage rather than IL-17
+
 Vγ6 γδT cells.  Previously, Smith et al. described a 
short feedback loop capable of regulating the transcription of IL-17 through the IL-17r 
signaling (2008); however, our studies show how IL-17r signaling can also regulate the 
proliferation of γδT17 perhaps through modulation of the RORγt-BTLA regulation 
pathway. Zhao et al. discovered that SerpinB1 plays a role in regulating γδT17 cells 
intrinsically through transcriptionally pushing γδ T cells to an IL-17 prominent effector 
phenotype (2014). It is plausible that SerpinB1 could be the link between the IL-17r 
signaling pathway and RORγt transcription regulation. Indeed, a drastic expansion of 
γδT17 cells in many tissues in the IL-17r
-/-
 mice suggests an intrinsic defect could be 
driving this phenotype.  Kumar et al. showed using IL-17r
-/-
 mice that increase levels of 
IL-17 in these mice is not due to lack of receptor clearance of IL-17 but instead caused by 
increase production of IL-17 by both Th17 cells and γδ T cells (Kumar et al., 2016).  
They also showed using CD4 specific IL-17r
-/-
 mice that lack of IL-17r does not cause an 
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intrinsic defect such as an endogenous increase in Th17 polarization or higher 
sensitization to polarization ligands upon exposure in vitro.  While Kumar et al. focused 
specifically on the lamina propria Th17 response which is most the most prominent affect 
in IL-17r
-/-
 gut, we focused on other peripheral tissues where the major affect was seen on 
γδT17 cells not Th17 cells.  However, we did not see γδT cell expansion in the thymus, 
colon or mLNs while oral draining cLNs were specifically affected with incongruous 
expansion. Therefore, we conclude that γδT17 peripheral regulation is mainly location 
and environment dependent.                    
Previous studies have shown the ability of microbiota to influence the expansion of 
γδT17 cells (Cheng et al., 2014; Wu et al., 2014). Here, we show that the expansion of 
γδT17 cells is transferred between mouse strains simply by co-housing WT and IL-17r
-/-
 
mice. Microbiota differences between the IL-17r
-/-
 and WT mice can be explained by the 
idea of “microbiota adaptation”. In the absence of IL-17 signaling, the microbiota and the 
immune system are trying to adapt and in essence reach a new equilibrium.  After all the 
presence of IL-17 has been constant for millions of years therefore the lack of IL-17 is a 
shock to both systems.  Even if the microbiota do not have an IL-17r on their own 
membranes, they still respond to signals downstream of endogenous IL-17 signaling such 
as secretion of antimicrobial products HBD2 and calgranulin by keratinocytes (Kolls et 
al., 2008). Cohousing WT mice with IL-17r
-/-
 mice may force the WT mouse’s oral 
microbiota to adapt and reach a new equilibrium which in turn results in an adaptation 
and adjustment by the WT mouse’s immune system shown here as an expansion of 
γδT17 cells. However, an important experiment to rule out gut microbiota contamination 
through consumption of fecal droppings was the fecal transfer experiment. The results 
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shows that gut microbiota as reported previously is important in Th17 induction in the 
colon (Goto et al., 2014; Ivanov et al., 2009; Wu et al., 2009). However, γδT17 cells are 
not affected by fecal transplant. Therefore, oral but not colonic microbiota is important in 
the peripheral regulation of γδT17. With the treatment of IL-17r
-/-
 mice with broad-
spectrum antibiotics through oral feeding, we completely abrogated γδT17 expansion in 
the periphery bringing the size and absolute cell number of IL-17r
-/-
 cLNs back to WT 
baseline levels, suggesting oral microbiota is critical in regulating γδT17 proliferation 
and maintenance.  It’s important to emphasize that the continued administration of oral 
broad-spectrum antibiotics from before birth to adulthood did not bring the cell count, 
size or IL-17 responses below that which is seen in WT mice.  The development, 
trafficking and regulation of these populations remained intact; however, we observed 
less expansion of the Vγ6 γδT17 population beyond average numbers.  These findings 
suggest a dichotomy in the regulation of the two major IL-17 production pathways which 
includes either Th17 or γδT17 cells.  As mentioned previously, extensive studies have 
shown the important in gut microbiota to regulate Th17 responses in gut lamina propria 
and the mesenteric lymph nodes.  Our data suggest that γδT17 cells are regulated not 
through gut microbiota but oral microbiota.  Perhaps with gut microbiota and food 
antigens placing such a central tolerigenic role on the gut immune system the necessity of 
a more dynamic cytokine response including Th polarlization and plasticity are better 
suited for the special microcosm of the host-environment.  However tolerance isn’t a 
primary role of oral immunity yet the microenvironment of the oral cavity is specialized 
since birth when babies begin sensing the world through their mouths.  The oral cavity 
immune system and microbiota must be well prepared for sensing and responding to 
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possible pathogenic microbes since this is perhaps the most important orifice for future 
infections.  Our GF mice studies show that in the absence of microbiota when compared 
to SPF mice Vγ6 γδT17 cells are at a minimal almost non-existent level even though total 
γδT cell frequency is not changed (data not shown).  This suggests that microbiota plays 
a specific regulatory role in the peripheral maintenance of IL-17 producing Vγ6 γδT cells 
but not Vγ4 and/or Vγ1 γδT cells.  We also observed a correlating drop in the CD103
+
 
DC population in the cLNs in the absence of microbiota supporting our hypothesis that 
microbiota regulated CD103
+
 DCs play a role in the maintenance and expansion of Vγ6 
γδT17 cells.  A well-known oral infection model that leads to microbiota dysbiosis is PG-
induced periodontal disease.  Using a chronic infection model with PG, we did in fact see 
increased levels of IL-17 producing cells that were specifically γδT17 cells as well as 
corresponding increasing levels of CD80
+
 CD103
+
 DCs though not statically significant. 
These findings suggest that oral diseases that affect the microbiota, i.e. periodontal 
disease, could have systemic effects on the immune system from γδT17 local expansion 
resulting in the initiation and/or progression of IL-17-driven inflammatory diseases.  
The gut is a very distinct immune site with Th17 cells playing the dominant role in 
epithelial integrity and immune responses.  This is understandable because it’s already 
been shown in arthritis, transplantation and gut disease models that Th17 cells can 
convert to Tregs and visa-versa (Komatsu et al., 2014; Obermajer et al., 2014; Omenetti 
and Pizarro, 2015).  The gut is such a dynamic, ever-changing environment that plasticity 
in the effector immune population is essential.  In contrast, the majority of γδT17 cells 
are pre-programmed in the embryonic thymus with low plasticity ability; therefore, they 
are likely designated to more stable epithelial barriers such as oral, lung and vagina 
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where tolerance is less important.  However, at these surfaces γδT17 have to respond 
immediately to any signs of threat with overwhelming IL-17. 
      In the physiological disease setting, differentiating IL-17 responses either from the 
gut or oral cavity could prove difficult due to fact that diseases that affect one location are 
also associated with simultaneous diseases that affect the other.  Epidemiology studies 
have shown that bad oral healthcare normally have bad overall nutrition (SHIMAZAKI, 
2007).  These patients potentially suffer from dental caries and/or gingivalis infections 
plus increase fats in the GI tract and obesity. Both pathologies occurring together would 
result in changes to the microbiota at the oral and gut interface inducing γδT17 and Th17 
responses simultaneously.  Our study however shows that oral microbiota seems to play a 
prominent role on systemic γδT17 populations while gut microbiota plays a more specific 
role on local Th17 responses.  
A more tangible question suggested by our study is that generic dysbiosis locally 
could result in increased γδT17 responses systemically. Whether antigen specificity is 
driving the proliferation and activation seen in our study is unknown.  γδT17 cells are 
efficient at recognizing cell stress and danger signals therefore general inflammation in 
many different models leads to expansion of γδT17 responses.  I think this might be why 
we see increase γδT17 cells in many different models including inflammation related 
cancers, autoimmune diseases and infections.  Again trying to pinpoint the response to 
either the initial dysbiosis or the ensuing inflammation is difficult.  In reality, these will 
cycle as ensuing inflammation leads to increased dysbiosis until the inflammation is 
finally resolved. 
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DC cross talk with γδT17 cells using cytokines IL-1β and IL-23 to induce 
proliferation and IL-17 production during inflammatory settings has been well described 
(Cai et al., 2011; Wu et al., 2014). Our ex vivo depletion and co-culture studies were 
designed to determine what led to the proliferation of γδT17 cells in IL-17r
-/-
 mice during 
steady-state conditions.  DCs, specifically the CD103
+
 DCs, in the cLNs of IL-17r
-/-
 can 
drive the proliferation of γδT17. This further supports our hypothesis that the observed 
proliferation and systemic expansion of γδT17 cells in the IL-17r
-/-
 mice is in fact 
location and environment dependent, perhaps due to “microbiota adaption” in the oral 
cavity. Mesenteric CD103
+
 DCs could not drive the proliferation of γδT17 cells but 
cervical CD103
+
 DCs with increased CD80 and CD86 upregulation could drive γδT17 
proliferation very strongly even lacking IL-1r. Although CD103
+
 DC induction of γδT17 
cell proliferation is independent of IL-1β or IL-1r signaling, a cell-to-cell contact is 
required for this process. These are novel results considering how well established DC 
cytokine induction, specifically through IL-1β/IL-23, is for γδT17 activation and 
proliferation. Previous studies showed that direct cell-to-cell contact between DCs and 
Vγ4
-
Vγ1
-
 γδ T cells could potentially be important in regulation of γδ T cell function 
(Wands et al., 2005). Our findings suggest a new regulatory network independent of 
soluble factors, dependent on APCs showing that γδT17 are not as socially inapt as once 
thought when compared to their conventional brothers and sisters, the αβ T cells. 
Regulatory cross talk between γδT17 and CD103
+
 DCs either through cytokine or cell-to-
cell interaction could be a major factor in how the immune system is able to respond and 
communicate with microbiota populations at the epithelial surface. Further investigation 
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will be needed to determine through what mechanism activated CD103
+
 DCs induce 
γδT17 proliferation. 
One of the most confusing issues in γδT17 biology has been what events are needed 
for γδT17 activation and cytokine secretion (Chien et al., 2014). While some γδ T cells 
responding to Ag stimulation in the periphery and undergoing Ag-specific differentiation 
into IL-17A-producing cells, such as phycoerythrin (PE)-specific γδ T cell response 
(Zeng et al., 2012), other γδ T cells make IL-17 within hours after an immune challenge. 
The rapid IL-17 response does not show an apparent explicit TCR engagement but 
requires inflammatory cytokines such as IL-1/IL-23 for its induction (Chien et al., 2013). 
These natural or innate like γδT17 cells have a highly focused TCR repertoire regardless 
of their anatomical origin (Wei et al., 2015). Wencker et al. reported previously that these 
γδ T cells require Ag recognition during thymic development which endows these cells to 
make IL-17 in response to cytokines in the periphery without engaging Ag (Wencker et 
al., 2014). Although the expanded γδT17 cells in IL-17r
-/-
 mice that we reported here 
have a highly invariant TCR repertoire, their monoclonal expansion is cell-to-cell contact 
dependent via interaction with activated CD103
+
 DCs. It is still probable that they can 
recognize an array of different molecules depending on molecular makeup and structure 
therefore acting more like a BCR on a B cell than the conventional αβ TCR. Further 
investigation is needed into determining what Ags are important for the homeostatic 
upkeep of γδT17 cells as well as proliferative induction of γδT17 cells during disease.  
Collectively, we propose a novel cellular pathway important in the regulation of host-
microbiota interactions. γδT17 are important in the maintenance of epithelial barrier 
function and CD103
+
 migratory DCs are important in microbiota Ag sampling (Duan et 
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al., 2010; Farache et al., 2013; O'Brien and Born, 2015; Schulz et al., 2009). Our findings 
connect the two processes and provide insights into how our body regulates this critical 
interface. Our results suggest that γδT17 and CD103
+
 DCs play a role of maintaining 
healthy microbiota populations at the epithelial surface in return being regulated 
themselves by the signals they receive from the microbiota. As the significance of γδT17 
cells continue to grow in a constantly expanding list of diseases they are associated with, 
therapeutic solutions targeting γδT17 will become a necessity. Finding specific targets to 
modulate this critical interaction could be beneficial to the homeostatic maintenance of 
normal microbiota populations as well as to many patients suffering from inflammation-
driven diseases. 
CONCLUSION, REMARKS AND FUTURE DIRECTION 
γδT17 cells are now considered both friend and foe depending on what context you 
study them in.  They are potent producers of IL-17, which is a powerful cytokine with 
many downstream affects mainly aimed towards inducing inflammation.  Most diseases 
involve inflammation initiating and progressing at the locations where γδT17 cells reside.  
An important area of investigation should focus at how these inflammatory cells are 
regulated and maintained in the periphery without causing damage during homeostasis 
yet are rapidly capable of providing enough inflammatory signals for pathogen clearance 
and/or wound repair.  In this study, we observed the tip of the γδT17 regulation iceberg 
with the discovery of a novel interaction and activation induction of γδT17 cells by oral 
microbiota activated CD103
+
 DCs.  As we dance and play in the macro world around us, 
γδT17 cells and CD103
+
 DCs stand guard and orchestrate the micro-world helping to 
bring about integration between host and microbiota.  Knowing that microbiota 
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influences the regulation of γδT17 cells and that microbiota are regulated by the primary 
effector cytokine produced by γδT17 cells, in the future we should aim to better 
understand the dance between these two populations.  CD103
+
 DCs appear to be 
mediators in the process but how exactly does this regulatory process tell who is friend or 
foe or even when too many friends begin to get out-of-control.  Future studies should 
focus on nailing out the details of these interactions determining what is critical to the 
maintenance of these two population and what are the signals being sent.  Super 
resolution microscopy and two-photon intravital microscopy can be utilized in order to 
get a better close-up look at how these populations interact (or “dance”) with each other.  
We could visualize the CD103
+
 DC network and how Vγ6 γδT17 cells interact with the 
network according to various stimuli applied in real time.  Ultimately these studies could 
lead to important applications for the health of patients by using new therapeutics to 
increase the beneficial role of this network and decreasing the unfortunate side-effects 
during different disease states.  Daily application of various creams for example which 
contain various probiotics or immunomodulators could be used to strength our immune 
system and prevent the onset of various diseases such as pathogen infection or 
autoimmune diseases.  The location of γδT17 cells at the epithelial surfaces provides an 
opportunity for less invasive therapeutic interventions.  Integration of the immune system 
with the microbiota and vice-a-versa is probably one of the most important least 
understood areas of biomedical research and the implications of the discoveries therein 
are too numerous to state here.  However the more we understand about this interface and 
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how it affects our health will provide key insights into how we treat disease and even 
more important how we prevent disease from occurring.
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Ph.D. Candidacy in Microbiology and Immunology, 2011-Current 
 
UNIVERSITY OF LOUISVILLE – Louisville, KY 
M.D. Candidacy, School of Medicine, 2009-2011 
 
UNIVERSITY OF LOUISVILLE – Louisville, KY 
 
 104 
MS in Microbiology and Immunology, 2011-2012 
 
CENTRE COLLEGE – Danville, KY  
BS Cum Laude in Biochemistry and Molecular Biology, 2005-2009 
 
OGLETHORPE COUNTY HIGH SCHOOL – Lexington, GA  
HS Diploma, College Prep, Valedictorian Award, 2001-2005 
 
 
Ph.D. Thesis 
 
James Graham Brown Cancer Center, University of Louisville – Louisville, KY 
Ph.D. Student & Research Fellow, 2011-Present 
Investigating how γδT17 cells are regulated in the periphery and maintained under 
homeostatic conditions and in disease.  γδT17 cells have been shown to play important 
roles in cancer and autoimmune inflammation drive pathogenesis therefore 
understanding how they are regulated in the periphery after development is critical to 
developing effective and specific immunotherapies in the future. 
Research Project Highlights: 
 Found a novel phenotype in the proliferation and expansion of γδT17 cells in mice 
lacking IL-17 receptor and that the phenotype is location and environment 
specific. 
 Found a new cellular regulation pathway between γδT17 cells and CD103+ DCs 
 Found that microbiota are essential for the peripheral regulation of γδT17 cells but 
not in tissues such as the colon, thymus and mesenteric lymph nodes. 
 Found that dysbiosis of oral microbiota either due to transfer of microbiota from 
IL-17r-/- to WT mice or by the infection of P. gingivalis leads to expansion of 
γδT17 cells in cervical LNs. 
 
 
Publications 
 
Fleming, C., Yihua Cai, Feng Xue, Yu-Ling Wei, Venkatakrishna Jala, Christopher 
Worth, Na Liu, Yueh-Hsiu Chien, Chuanlin Ding, Jun Yan. “Microbiota Activated 
CD103+ DCs Stemming from Oral Microbiota Adaptation Specifically Drive 
γδT17 Proliferation and Activation.”  [Submitted to Nature Immunology] 
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Yan, J., Kloeker, G., Fleming, C., Bousamra, M., Hansen, R., Hu, X., Ding, C., Cai, Y., 
Dong, X., Donninger, H., Eaton, J., Clark, G.. " Human Polymorphonuclear 
Neutrophils Specifically Recognize Tumor Cells for Killing.” Oncoimmunology. 
2014 Jul 3;3(7):e950163. 
 
Cai, Y., Xuefeng, X., Fleming, C., Yan, J. "Differential Developmental Requirement for 
Dermal IL-17-producing Vγ4 and Vγ6 T Cells and Their Peripheral Regulation in 
Health and Skin Inflammation.” Nat Commun. 2014 Jun 9;5:3986. doi: 
10.1038/ncomms4986. 
 
Cai, Y., Fleming, C., & Yan, J. (2013). Dermal γδ T cells - A new player in the 
pathogenesis of psoriasis. International immunopharmacology. 
doi:10.1016/j.intimp.2013.02.018 
 
Cai, Y., Fleming, C., & Yan, J. (2012). New insights of T cells in the pathogenesis of 
psoriasis. Cellular and Molecular Immunology, 9(4), 302–309. 
doi:10.1038/cmi.2012.15 
 
 
Research Internships 
 
James Graham Brown Cancer Center – Louisville, KY 
Research Intern (SROP program), Dr. Jun Yan and Dr. John Eaton, Department of 
Medicine, June-August 2009 
The purpose of this research was to ascertain whether Cisplatin treated NSCLC cancer 
patients are immunologically compromised due to inhibition of neutrophil killing.  After 
getting IRB approval, a small clinical study was conducted in order to acquire blood 
samples from over 50 healthy donors and cancer patients.  Using blood samples, 
neutrophils were isolated and comparison studies of their neutrophils were done using 
an in vitro cytotoxicity assay (Label-free ACEA cytolysis assay), flow cytometry for 
surface marker expression and an NBT assay (nitro blue tetrazolium) in order to 
compare difference in respiratory burst.  The results of the study were that patients 
treated with cisplatin have less neutrophil killing and this results from an inhibition of 
respiratory burst function. 
 
Barbados Wildlife Reserve – Barbados, W.I. 
Research Intern (Centre Study Abroad), Drs. Brian Cusato and Melissa Burns-
Cusato , Department of Psychology, January 2009 
This research experience was part of Centre’s study abroad program (PYB450 
Research in Primate Behavior) where observations and recordings were made of the 
behavior and migration patterns of wild vervet monkeys as they cross in-and-out of the 
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Barbados Wildlife Research to avoid predators and the local communities.  Different 
behaviors and migration patterns observed between different matriarchal families were 
recorded in detail using a computer then mapped out later for presentation.  The title of 
the project was “The Migration Patterns and Behaviors of Vervet Monkeys near the 
Barbados Wildlife Reserve.”  Our group won a competition between 8 groups for a 
presentation spot at the Southwest Psychology Association Meeting in San Antonio, TX.  
A Powerpoint presentation was also given at Centre’s R.I.C.E. symposium in April of 
2009. 
 
Medical University of South Carolina – Charleston, SC 
Research Intern (SURE Program), Dr. David Cole, Department of Immunology, 
June-August 2008 
Investigating how to optimize the killing efficiency of CD8 T cells against melanoma 
using Adoptive T Cell Therapy (ACT).  Having acquired a proficient skill level for 
immunology lab techniques the previous summer at the Mayo Clinic, Drs. Cole and 
Montero-Diaz allowed an independent research experience in terms of experimental 
design and execution.  The purpose of the research titled “Therapeutic Efficacy of T 
Cells Specific for Human Tyrosinase in the Treatment of Melanoma” was to examine the 
therapeutic efficacy of T cells from Human Tyrosinase TIL-derived Transgenic (H3T) 
mice after ACT.  Traditional T cell expansion for ACT against melanoma used IL-2 
cytokine treatment however we found that by using IL-12 the therapeutic efficacy of ACT 
is increased.  The conclusions from the research were that H3T mice are able to reject 
B16-A2 tumors that present tyrosinase epitopes in the context of human HLA-A2 
molecules.  ACT of IL-12 versus IL-2 ex vivo activated H3T T cells increases the survival 
of mice bearing B16-A2 melanoma tumors.  IL-12 treatment increases T cell proliferation 
and expression of CD62L, CD127, and IFN-γ prior to ACT.  H3T mice represent a good 
model to optimize the activation condition of T cells prior to ACT.  A Powerpoint 
presentation was presented at the MUSC SURE Closing Banquet and at the Centre 
College R.I.C.E. Symposium the following Spring. 
 
Mayo Clinic – Rochester, MN 
Research Intern (SURP Program), Dr. Larry Pease, Department of Immunology, 
June-August 2007 
First experience doing wet lab research and learned how to harvest bone marrow for DC 
differentiation and lymphocytes from lymph nodes, perform Cr release cytotoxicity 
assays, flow cytometry, ELISA and western blots and by the end of the summer I was 
able to do all these assays independently.  The project was titled “Phenotypic and 
Functional Differences of OT1 T cells activated with B7-DC Crosslinking antibody (XAb) 
in vitro for 24 hours.” The purpose was to look at the phenotypic differences of CD8 OT-I 
T cells after 24 hours co-culture with bone marrow derived dendritic cells that had been 
activated with melanoma lysate plus B7-DC Xab (isolated from a Mayo patient with 
Waldenstrom’s macroglobulinemia in 2000) or melanoma lysate plus control antibody. 
The results were that B7-DC Xab increased cytotoxicity of B16-F10 and EG7 tumor cells 
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by CD8 T cells, no difference in surface activation markers or IFN-γ production was 
observed and tyrosine phosphorylation was increased in the stimulated CD8 T cells.  A 
Powerpoint presentation was presented at the Mayo Clinic SURP Closing Banquet and 
at Centre College the following spring at the Centre R.I.C.E. Symposium. 
 
 
Awards 
 
2013- Midwest Regional American Physician Scientists Association 1st Place Graduate 
Poster Award 
2013- James Graham Brown Cancer Center 1st Place Graduate Research Award 
2013- ResearchLouisville! First Place Doctoral Student Award  
2011- UofL Sponsored Research Tuition Award 
2007- W. Burford Davis Memorial Scholarship  
2007- Combs Achievement Award for Academic Excellence  
2006- Gold Presidential Service Award (400+ annual volunteering hours) 
2005-2009- Four Dean’s List Recognitions, Centre College 
2005- Athens Area Human Relations, Inc. – Dana and Zoe Memorial Scholarship 
2005- Elk’s Lodge 1st Place Most Valuable Student Award for Northeast Georgia  
2005- Valedictorian of Oglethorpe County High School  
 
 
Presentations 
Oral  
Fleming, C., Diaz-Monterro, M., Cole, D. Therapeutic Efficacy of T Cells Specific 
for Human Tyrosinase in the Treatment of Melanoma. Centre RICE Symposium 
2009.  Centre College, Danville, KY. April 2009. 
Fleming, C., Royalty, S., Cusato, B., Cusato, M. The Migration Patterns and 
Behaviors of Vervet Monkeys near the Barbados Wildlife Reserve.  Centre RICE 
Symposium 2009.  Centre College, Danville, KY. April 2009.  
Fleming, C., Royalty, S., Cusato, B., Cusato, M. The Migration Patterns and 
Behaviors of Vervet Monkeys near the Barbados Wildlife Reserve.  Southwest 
Psychology Association Annual Conference.  San Antonio, TX. April 2009. 
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Fleming, C., Diaz-Monterro, M., Cole, D. Therapeutic Efficacy of T Cells Specific 
for Human Tyrosinase in the Treatment of Melanoma. MUSC SURE Closing 
Banquet.  MUSC, Charleston, SC. August 2008. 
Fleming, C., Schenk, E., Radhakrishnan, S., Pease, L. Phenotypic and Functional 
Differences of OT1 T cells activated with B7-DC XAb in vitro for 24 hours.  Centre 
RICE Symposium 2008.  Centre College, Danville, KY. April 2008. 
Fleming, C., Schenk, E., Radhakrishnan, S., Pease, L. Phenotypic and Functional 
Differences of OT1 T cells activated with B7-DC XAb in vitro for 24 hours.  Mayo 
Clinic SURP Closing Banquet.  Mayo Clinic, Rochester, MN. August 2007. 
Poster  
Fleming, C., Cai, Y., Sun, X., Jala, K., Wei, Y…. Yan, J.  The Extrinsic and Intrinsic 
Regulation of γδT17 cells through the IL-17-IL-17r axis during homeostasis.  
ResearchLouisville!  Louisville, KY. September 2015. 
Fleming, C., Cai, Y., Sun, X., Jala, K., Wei, Y…. Yan, J. The Extrinsic and Intrinsic 
Regulation of γδT17 cells through the IL-17-IL-17r axis during homeostasis. 2015 
AAI Meeting New Orleans  New Orleans, LA. May 2015. 
Fleming, C., Cai, Y., Yunfeng, M., Fengling, L., Teng, T., Yan, J.  Characterization 
of IL-17 Producing γδ T cells in the Lungs: Implications for Lung Cancer 
Development and Metastasis.  American Physician Scientists Association 
Midwest Conference.  Columbus, OH. November 2013. 
Fleming, C., Cai, Y., Yunfeng, M., Fengling, L., Teng, T., Yan, J.  Characterization 
of IL-17 Producing γδ T cells in the Lungs: Implications for Lung Cancer 
Development and Metastasis.  James Graham Brown Cancer Center Annual 
Retreat.  Louisville, KY. October 2013. 
Fleming, C., Cai, Y., Yunfeng, M., Fengling, L., Teng, T., Yan, J.  Characterization 
of IL-17 Producing γδ T cells in the Lungs: Implications for Lung Cancer 
Development and Metastasis.  ResearchLouisville!  Louisville, KY. September 
2013. 
 
Affiliations 
 
Current 
American Association of Immunologists 
Microbiology and Immunology  
Past 
American Medical Association   
American College of Physicians 
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Student Organization  Kentucky Academy of Sciences 
American Physician Scientist Association 
Phi Delta Epsilon (2009-2011) 
Drive Cancer Out (2009-2011) 
St. Jude Up Til’ Dawn (2006-2009) 
Alpha Phi Omega (2006-2009) 
Beta Beta Beta (2008-2009) 
 
 
 
Professional Skill Set 
 
Multi-color Flow Cytometry (6 colors) and Cell 
Sorting (8 colors) 
Mouse Husbandry, Breeding, and Development 
Adoptive Cell therapy and in vivo mouse studies 
Irradiation and Bone marrow transplants 
Microscopy (confocal) 
Mouse Handling 
 Injections (Subcut, IV, Peritoneal) 
 Anesthetics (Catamine/isofluorane)  
 Euthanization  
 Necropsy  
 
Genotyping 
Genomic DNA extraction from tissue 
Western Blot 
Northern Blot 
E.L.I.S.A. 
RT-PCR 
Cromium Release Cytolysis Assay 
ACEA Label-Free Cytolysis Assay 
CFSE Proliferation Assay 
Chromatography 
 Gel 
 Affinity 
 Ion-exchange 
 
